0000021665-21-000010.txt : 20210430 0000021665-21-000010.hdr.sgml : 20210430 20210430085919 ACCESSION NUMBER: 0000021665-21-000010 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 62 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 21874042 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 10-Q 1 cl-20210331.htm 10-Q cl-20210331
000002166512/312021Q1false00000216652021-01-012021-03-310000021665us-gaap:CommonStockMember2021-01-012021-03-310000021665cl:A0.000Notesdue2021Member2021-01-012021-03-310000021665cl:A0.500NotesDue2026Member2021-01-012021-03-310000021665cl:A1.375NotesDue2034Member2021-01-012021-03-310000021665cl:A0.875Notesdue2039Member2021-01-012021-03-31xbrli:shares00000216652021-03-31iso4217:USD00000216652020-01-012020-03-31iso4217:USDxbrli:shares00000216652020-12-3100000216652019-12-3100000216652020-03-310000021665us-gaap:CommonStockMember2020-12-310000021665us-gaap:AdditionalPaidInCapitalMember2020-12-310000021665cl:UnearnedCompensationMember2020-12-310000021665us-gaap:TreasuryStockMember2020-12-310000021665us-gaap:RetainedEarningsMember2020-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000021665us-gaap:NoncontrollingInterestMember2020-12-310000021665us-gaap:RetainedEarningsMember2021-01-012021-03-310000021665us-gaap:NoncontrollingInterestMember2021-01-012021-03-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000021665us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000021665us-gaap:TreasuryStockMember2021-01-012021-03-310000021665cl:UnearnedCompensationMember2021-01-012021-03-310000021665us-gaap:CommonStockMember2021-03-310000021665us-gaap:AdditionalPaidInCapitalMember2021-03-310000021665cl:UnearnedCompensationMember2021-03-310000021665us-gaap:TreasuryStockMember2021-03-310000021665us-gaap:RetainedEarningsMember2021-03-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000021665us-gaap:NoncontrollingInterestMember2021-03-310000021665us-gaap:CommonStockMember2019-12-310000021665us-gaap:AdditionalPaidInCapitalMember2019-12-310000021665cl:UnearnedCompensationMember2019-12-310000021665us-gaap:TreasuryStockMember2019-12-310000021665us-gaap:RetainedEarningsMember2019-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000021665us-gaap:NoncontrollingInterestMember2019-12-310000021665us-gaap:RetainedEarningsMember2020-01-012020-03-310000021665us-gaap:NoncontrollingInterestMember2020-01-012020-03-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310000021665us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000021665us-gaap:TreasuryStockMember2020-01-012020-03-310000021665cl:UnearnedCompensationMember2020-01-012020-03-310000021665us-gaap:CommonStockMember2020-03-310000021665us-gaap:AdditionalPaidInCapitalMember2020-03-310000021665cl:UnearnedCompensationMember2020-03-310000021665us-gaap:TreasuryStockMember2020-03-310000021665us-gaap:RetainedEarningsMember2020-03-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000021665us-gaap:NoncontrollingInterestMember2020-03-31cl:Dividend0000021665cl:HelloProductLLCMember2020-01-312020-01-310000021665cl:HelloProductLLCMember2020-01-310000021665cl:HelloProductLLCMemberus-gaap:TrademarksMember2020-01-310000021665cl:HelloProductLLCMemberus-gaap:TrademarksMember2020-01-312020-01-310000021665cl:HelloProductLLCMemberus-gaap:CustomerRelationshipsMember2020-01-310000021665cl:HelloProductLLCMemberus-gaap:CustomerRelationshipsMember2020-01-312020-01-310000021665cl:HelloProductLLCMembersrt:NorthAmericaMember2020-01-310000021665cl:GlobalGrowthandEfficiencyProgramMember2021-01-012021-03-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-01-012020-03-310000021665cl:GlobalGrowthandEfficiencyProgramMember2021-03-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-03-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-03-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-01-012021-03-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-03-310000021665us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-01-012021-03-310000021665us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-03-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-03-31cl:country_and_territory0000021665srt:MinimumMember2021-03-310000021665srt:MaximumMember2021-03-31cl:case00000216652005-12-3100000216652017-07-3100000216652019-04-3000000216652019-10-012019-12-31cl:segment0000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:EuropeMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembersrt:EuropeMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembercl:AfricaEurasiaMembercl:OralPersonalAndHomeCareMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembercl:AfricaEurasiaMembercl:OralPersonalAndHomeCareMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-01-012020-03-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2021-01-012021-03-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2020-01-012020-03-31xbrli:pure0000021665us-gaap:SalesRevenueNetMember2021-03-310000021665cl:OralCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-03-310000021665cl:OralCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-03-310000021665cl:PersonalCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-03-310000021665cl:PersonalCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-03-310000021665cl:HomeCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-03-310000021665cl:HomeCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-03-310000021665cl:PetNutritionMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-03-310000021665cl:PetNutritionMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-03-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-03-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-03-310000021665us-gaap:CorporateNonSegmentMember2021-01-012021-03-310000021665us-gaap:CorporateNonSegmentMember2020-01-012020-03-310000021665us-gaap:CorporateNonSegmentMemberus-gaap:OperatingIncomeLossMember2020-01-012020-03-310000021665us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMember2021-03-310000021665us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMember2021-03-310000021665us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:OtherAssetsMemberus-gaap:ForwardContractsMember2021-03-310000021665us-gaap:OtherAssetsMemberus-gaap:ForwardContractsMember2020-12-310000021665us-gaap:OtherLiabilitiesMemberus-gaap:ForwardContractsMember2021-03-310000021665us-gaap:OtherLiabilitiesMemberus-gaap:ForwardContractsMember2020-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2021-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2020-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-03-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMember2021-03-310000021665us-gaap:CommodityContractMemberus-gaap:OtherCurrentAssetsMember2020-12-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:CommodityContractMember2021-03-310000021665us-gaap:OtherCurrentLiabilitiesMemberus-gaap:CommodityContractMember2020-12-310000021665us-gaap:OtherCurrentAssetsMember2021-03-310000021665us-gaap:OtherCurrentAssetsMember2020-12-310000021665us-gaap:FairValueInputsLevel2Member2021-03-310000021665us-gaap:FairValueInputsLevel2Member2020-12-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000021665us-gaap:LongTermDebtMember2021-03-310000021665us-gaap:LongTermDebtMember2020-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMember2021-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:DebtMember2021-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2021-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForwardContractsMember2021-03-310000021665us-gaap:CommodityContractMemberus-gaap:FairValueHedgingMember2021-03-310000021665us-gaap:FairValueHedgingMember2021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:DebtMember2021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-03-310000021665us-gaap:CashFlowHedgingMember2021-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-03-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2021-03-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-03-310000021665us-gaap:ForwardContractsMemberus-gaap:NetInvestmentHedgingMember2021-03-310000021665us-gaap:CommodityContractMemberus-gaap:NetInvestmentHedgingMember2021-03-310000021665us-gaap:NetInvestmentHedgingMember2021-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:DebtMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForwardContractsMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:FairValueHedgingMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:DebtMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2020-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2020-12-310000021665us-gaap:CashFlowHedgingMember2020-12-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2020-12-310000021665us-gaap:ForwardContractsMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:CommodityContractMemberus-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:NetInvestmentHedgingMember2020-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2021-01-012021-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2020-01-012020-03-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2020-01-012020-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2021-01-012021-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMember2021-01-012021-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMember2020-01-012020-03-310000021665us-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueHedgingMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMembercl:InterestIncomeExpenseNetMember2021-01-012021-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMembercl:InterestIncomeExpenseNetMember2020-01-012020-03-310000021665us-gaap:CostOfSalesMember2021-01-012021-03-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000021665cl:InterestIncomeExpenseNetMember2021-01-012021-03-310000021665us-gaap:CostOfSalesMember2020-01-012020-03-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000021665cl:InterestIncomeExpenseNetMember2020-01-012020-03-310000021665us-gaap:ForeignExchangeContractMember2021-01-012021-03-310000021665us-gaap:ForeignExchangeContractMember2020-01-012020-03-310000021665us-gaap:ForwardContractsMember2021-01-012021-03-310000021665us-gaap:ForwardContractsMember2020-01-012020-03-310000021665us-gaap:CommodityContractMember2021-01-012021-03-310000021665us-gaap:CommodityContractMember2020-01-012020-03-310000021665us-gaap:DebtMember2021-01-012021-03-310000021665us-gaap:DebtMember2020-01-012020-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
_________________________
 (Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from________ to________ .
Commission File Number: 1-644
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware13-1815595
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
 
300 Park Avenue
New York,New York10022
(Address of principal executive offices)(Zip Code)
(212) 310-2000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par valueCLNew York Stock Exchange
0.000% Notes due 2021CL21ANew York Stock Exchange
0.500% Notes due 2026CL26New York Stock Exchange
1.375% Notes due 2034CL34New York Stock Exchange
0.875% Notes due 2039CL39New York Stock Exchange

NO CHANGES
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒  No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
ClassShares OutstandingDate
Common stock, $1.00 par value845,968,780March 31, 2021



PART I.    FINANCIAL INFORMATION


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Income
(Dollars in Millions Except Per Share Amounts)
(Unaudited)
 
 Three Months Ended
March 31,
20212020
Net sales$4,344 $4,097 
Cost of sales1,707 1,632 
Gross profit2,637 2,465 
Selling, general and administrative expenses1,605 1,473 
Other (income) expense, net28 40 
Operating profit1,004 952 
Non-service related postretirement costs18 21 
Interest (income) expense, net29 36 
Income before income taxes957 895 
Provision for income taxes229 147 
Net income including noncontrolling interests728 748 
Less: Net income attributable to noncontrolling interests47 33 
Net income attributable to Colgate-Palmolive Company$681 $715 
Earnings per common share, basic$0.80 $0.83 
Earnings per common share, diluted$0.80 $0.83 



See Notes to Condensed Consolidated Financial Statements.

2



COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Comprehensive Income
(Dollars in Millions)
(Unaudited)
Three Months Ended
March 31,
20212020
Net income including noncontrolling interests$728 $748 
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments(158)(355)
Retirement plans and other retiree benefit adjustments2 16 
    Gains (losses) on cash flow hedges43 18 
Total Other comprehensive income (loss), net of tax(113)(321)
Total Comprehensive income including noncontrolling interests615 427 
Less: Net income attributable to noncontrolling interests47 33 
Less: Cumulative translation adjustments attributable to noncontrolling interests(3)(16)
Total Comprehensive income attributable to noncontrolling interests44 17 
Total Comprehensive income attributable to Colgate-Palmolive Company$571 $410 
See Notes to Condensed Consolidated Financial Statements.

3


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Balance Sheets
(Dollars in Millions)
(Unaudited)
March 31,
2021		December 31,
2020
Assets
Current Assets
Cash and cash equivalents$995 $888 
Receivables (net of allowances of $89 and $89, respectively)
1,402 1,264 
Inventories1,676 1,673 
Other current assets490 513 
Total current assets4,563 4,338 
Property, plant and equipment:  
Cost8,637 8,751 
Less: Accumulated depreciation(5,028)(5,035)
 3,609 3,716 
Goodwill3,701 3,824 
Other intangible assets, net2,787 2,894 
Deferred income taxes201 291 
Other assets940 857 
Total assets$15,801 $15,920 
Liabilities and Shareholders’ Equity  
Current Liabilities  
Notes and loans payable$254 $258 
Current portion of long-term debt9 9 
Accounts payable1,306 1,393 
Accrued income taxes422 403 
Other accruals2,548 2,341 
Total current liabilities4,539 4,404 
Long-term debt7,570 7,334 
Deferred income taxes415 426 
Other liabilities2,614 2,655 
Total liabilities15,138 14,819 
Shareholders’ Equity  
Common stock1,466 1,466 
Additional paid-in capital3,011 2,969 
Retained earnings23,624 23,699 
Accumulated other comprehensive income (loss)(4,455)(4,345)
Unearned compensation— (1)
Treasury stock, at cost(23,384)(23,045)
Total Colgate-Palmolive Company shareholders’ equity262 743 
Noncontrolling interests401 358 
Total equity663 1,101 
Total liabilities and equity$15,801 $15,920 
See Notes to Condensed Consolidated Financial Statements.

4


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Cash Flows
(Dollars in Millions)
(Unaudited)
Three Months Ended
 March 31,
 20212020
Operating Activities  
Net income including noncontrolling interests$728 $748 
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:  
Depreciation and amortization137 133 
Restructuring and termination benefits, net of cash(13)(30)
Stock-based compensation expense38 16 
Deferred income taxes6 (99)
Cash effects of changes in:
Receivables(170)(211)
Inventories(40)29 
Accounts payable and other accruals(75)220 
Other non-current assets and liabilities(13)(38)
Net cash provided by (used in) operations598 768 
Investing Activities  
Capital expenditures(107)(82)
Purchases of marketable securities and investments(29)(42)
Proceeds from sale of marketable securities and investments— 16 
Payment for acquisitions, net of cash acquired— (351)
Other investing activities(6)— 
Net cash provided by (used in) investing activities(142)(459)
Financing Activities  
Short-term borrowing (repayment) less than 90 days, net365 17 
Proceeds from issuance of debt 25 — 
Dividends paid(376)(373)
Purchases of treasury shares(372)(220)
Proceeds from exercise of stock options30 297 
Other financing activities(6)(29)
Net cash provided by (used in) financing activities(334)(308)
Effect of exchange rate changes on Cash and cash equivalents(15)(30)
Net increase (decrease) in Cash and cash equivalents107 (29)
Cash and cash equivalents at beginning of the period888 883 
Cash and cash equivalents at end of the period$995 $854 
Supplemental Cash Flow Information  
Income taxes paid$227 $128 
See Notes to Condensed Consolidated Financial Statements.

5


COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Changes in Shareholders’ Equity
(Dollars in Millions)
(Unaudited)
Three Months Ended March 31, 2021
Colgate-Palmolive Company Shareholders’ Equity
Common
Stock		Additional
Paid-in
Capital		Unearned
Compensation		Treasury
Stock		Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)(1)
Noncontrolling
Interests
Balance, December 31, 2020$1,466 $2,969 $(1)$(23,045)$23,699 $(4,345)$358 
Net income— — — — 681 — 47 
Other comprehensive income (loss), net of tax
— — — — — (110)(3)
Dividends ($0.89 per share)*
— — — — (756)— — 
Stock-based compensation expense
— 38 — — — — — 
Shares issued for stock options
— 13 — 22 — — — 
Shares issued for restricted stock units
— (11)— 11 — — — 
Treasury stock acquired
— — — (372)— — — 
Other— 2 1 — — — (1)
Balance, March 31, 2021$1,466 $3,011 $— $(23,384)$23,624 $(4,455)$401 
Three Months Ended March 31, 2020
Colgate-Palmolive Company Shareholders’ Equity
Common
Stock		Additional
Paid-in
Capital		Unearned
Compensation		Treasury
Stock		Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)(1)
Noncontrolling
Interests
Balance, December 31, 2019$1,466 $2,488 $(2)$(22,063)$22,501 $(4,273)$441 
Net income— — — — 715 — 33 
Other comprehensive income (loss), net of tax
— — — — — (305)(16)
Dividends ($0.87 per share)*
— — — — (738)— (4)
Stock-based compensation expense
— 16 — — — — — 
Shares issued for stock options
— 133 — 164 — — — 
Shares issued for restricted stock units
— (15)— 15 — — — 
Treasury stock acquired
— — — (220)— — — 
Other— 1 1 — 3 — — 
Balance, March 31, 2020$1,466 $2,623 $(1)$(22,104)$22,481 $(4,578)$454 
(1) Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,313 at March 31, 2021 ($3,467 at March 31, 2020) and $3,158 at December 31, 2020 ($3,128 at December 31, 2019), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,176 at March 31, 2021 ($1,122 at March 31, 2020) and $1,178 at December 31, 2020 ($1,138 at December 31, 2019), respectively.
* Two dividends were declared in each of the first quarters of 2021 and 2020.




See Notes to Condensed Consolidated Financial Statements.

6

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)

1.    Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission (the “SEC”).

2.     Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

3.    Recent Accounting Pronouncements

In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-01, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
7
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


4.    Acquisitions

Hello Products LLC (“hello”)

On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:
Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 
Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships, valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.






8
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


5.    Restructuring and Related Implementation Charges
    
The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019 and no new restructuring projects were approved for implementation subsequent to the conclusion of the Global Growth and Efficiency Program.

During the three months ended March 31, 2021 and March 31, 2020, the Company made cash payments of $13 and $30, respectively, related to projects approved prior to the conclusion of the Global Growth and Efficiency Program.

The accrual balance at March 31, 2021 and December 31, 2020 was $19 and $31, respectively.
9
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


6.    Inventories

Inventories by major class are as follows:
March 31,
2021		December 31,
2020
Raw materials and supplies$463 $454 
Work-in-process48 45 
Finished goods1,264 1,256 
       Total Inventories, net$1,775 $1,755 
            Non-current inventory, net$(99)$(82)
              Current Inventories, net$1,676 $1,673 
7.    Earnings Per Share

For the three months ended March 31, 2021 and 2020, earnings per share were as follows:
 Three Months Ended
 March 31, 2021March 31, 2020
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share		Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share
Basic EPS$681 848.6 $0.80 $715 856.9 $0.83 
Stock options and
restricted stock units
2.8   1.5  
Diluted EPS$681 851.4 $0.80 $715 858.4 $0.83 
For the three months ended March 31, 2021 and 2020, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,721,084 and 20,965,110, respectively.

10
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


8.    Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2021 and 2020 were as follows:
 20212020
PretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(99)$(155)$(320)$(339)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period(19)(14)2 1 
Amortization of net actuarial loss, transition and prior service costs (1)
22 16 17 15 
Retirement plans and other retiree benefits adjustments3 2 19 16 
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges53 41 25 20 
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
3 2 (3)(2)
Gains (losses) on cash flow hedges56 43 22 18 
Total Other comprehensive income (loss)$(40)$(110)$(279)$(305)
(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.



9.    Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2021 and 2020 were as follows:
Three Months Ended March 31, 2021
 Pension BenefitsOther Retiree Benefits
 United StatesInternational  
 202120202021202020212020
Service cost$— $— $4 $4 $6 $6 
Interest cost15 19 5 5 9 11 
Expected return on plan assets(27)(27)(6)(4)— — 
Amortization of actuarial loss (gain)13 11 3 1 6 5 
Net periodic benefit cost
$1 $3 $6 $6 $21 $22 

For the three months ended March 31, 2021 and 2020, the Company made no voluntary contributions to its U.S. postretirement plans.
11
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


10.    Income Taxes

The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the “TCJA”).

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes would be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, in the first quarter of 2020, reversed $45 of previously recorded foreign withholding taxes.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, in the first quarter of 2020, reversed the previously recorded valuation allowance of $26.

11.    Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $400 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

12
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $103. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.

In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $45, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

13
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Competition Matter

Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of March 31, 2021 of such competition law matters pending against the Company during the three months ended March 31, 2021 is set forth below.

▪In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2021, there were 147 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 137 cases as of December 31, 2020. During the three months ended March 31, 2021, 14 new cases were filed and three cases were resolved by voluntary dismissal. In addition, during the three months ended March 31, 2021, the Company won an appeal in one case that, in 2019, resulted in a jury verdict in favor of the Company and, since all of the plaintiff’s appeals have been exhausted, the case is now closed. There were no settlements of pending cases in the three months ended March 31, 2021.

A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes a portion of such costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.
14
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


12.    Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
Three Months Ended
 March 31,
 20212020
Net sales  
Oral, Personal and Home Care  
North America$923 $929 
Latin America907 889 
Europe717 675 
Asia Pacific739 633 
Africa/Eurasia272 252 
Total Oral, Personal and Home Care3,558 3,378 
Pet Nutrition786 719 
Total Net sales$4,344 $4,097 
Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
15
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Three Months Ended
 March 31,
 20212020
Net sales
Oral Care45 %44 %
Personal Care19 %20 %
Home Care18 %18 %
Pet Nutrition18 %18 %
Total Net sales100 %100 %
Operating profit by segment was as follows:
Three Months Ended
 March 31,
 20212020
Operating profit  
Oral, Personal and Home Care  
North America$202 $258 
Latin America272 248 
Europe180 154 
Asia Pacific224 161 
Africa/Eurasia54 56 
Total Oral, Personal and Home Care932 877 
Pet Nutrition215 203 
Corporate(143)(128)
Total Operating profit$1,004 $952 
For the three months ended March 31, 2020, Corporate Operating profit (loss) included acquisition-related costs of $6.

16
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


13.    Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2021 and December 31, 2020:
 AssetsLiabilities
  
Account		Fair ValueAccountFair Value
Designated derivative instrumentsMarch 31, 2021December 31, 2020 March 31, 2021December 31, 2020
Interest rate swap contractsOther assets$11 $14 Other liabilities$— $— 
Forward-starting interest rate swapsOther assets51 5 Other liabilities— — 
Foreign currency contractsOther current assets13 7 Other accruals55 93 
Commodity contractsOther current assets2 3 Other accruals— — 
Total designated$77 $29  $55 $93 
Other financial instruments     
Marketable securitiesOther current assets$62 $37    
Total other financial instruments$62 $37    
17
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of March 31, 2021 and December 31, 2020. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2021 and December 31, 2020, was $8,097 and $8,175, respectively, and the related carrying value was $7,579 and $7,343, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:
March 31, 2021December 31, 2020
Long-term debt:  
Carrying amount of hedged item$411 $413 
Cumulative hedging adjustment included in the carrying amount11 14 
The following tables present the notional values as of:
 March 31, 2021
 Foreign Currency ContractsForeign Currency DebtInterest Rate Swaps Forward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $527 $— $400 $— $— $927 
Cash Flow Hedges 825 — — 600 19 1,444 
Net Investment Hedges604 4,164 — — — 4,768 
 December 31, 2020
 Foreign Currency ContractsForeign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $— $400 $— $— $989 
Cash Flow Hedges 854 — — 300 17 1,171 
Net Investment Hedges528 4,523 — — — 5,051 
18
COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
Three Months Ended March 31,
 20212020
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Interest rate swaps designated as fair value hedges:
Derivative instrument$— $— $2 $— $— $(12)
Hedged items— — (2)— — 12 
Foreign currency contracts designated as fair value hedges:
Derivative instrument— — — — 24 — 
Hedged items— — — — (24)— 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI(6)— — 2 — — 
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI3 — — 1 — — 
Total gain (loss) on hedges recognized in income$(3)$— $— $3 $— $— 


The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
20212020
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$6 $25 
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI46 — 
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI1 — 
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments23 25 
Gain (loss) on hedged items(23)(25)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments211 65 
Gain (loss) on hedged items(211)(65)
Total unrealized gain (loss) on hedges recognized in OCI$53 $25 




19
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Executive Overview

Business Organization

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us” “our” the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as to provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion strategies across our organization.

We are tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, we follow a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which we compete, we prioritize our efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable, profitable long-term growth.

Operationally, we are organized along geographic lines with management teams having responsibility for the business and financial results in each region. We compete in more than 200 countries and territories worldwide with established businesses in all regions contributing to our sales and profitability. Approximately 70% of our Net sales are generated from markets outside the U.S., with approximately 45% of our Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce our exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors. Through Hill’s Pet Nutrition, we also compete on a worldwide basis in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and eCommerce retailers. We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing facilities, warehousing facilities and distribution centers in every region around the world.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. In addition, we review market share data to assess how our brands are performing within their categories on a global and regional basis. The monitoring of these indicators and our Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures and the Company’s use of market share data and the limitations of such data, see “Non-GAAP Financial Measures” and “Market Share Information” below.
















20
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

COVID-19

The COVID-19 pandemic and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have a profound impact on the way people live, work, interact and shop and have significantly impacted and will likely continue to impact economic activity around the world. We have a well-established Crisis Management Team (“CMT”) process, and the CMT, together with our senior management team and Colgate people around the world, continue to respond to and manage the challenges presented by COVID-19.

During the COVID-19 pandemic, many of the communities in which we manufacture, market and sell our products have experienced unprecedented “stay at home” orders, travel or movement restrictions and other government actions to reduce the spread and address the impact of COVID-19, and have implemented varying policies to resume economic activity and distribute effective vaccines. The situation continues to be uncertain and varies by geography, as infection rates of COVID-19 remain high in many regions throughout the world, including Brazil, India and Mexico where we have substantial manufacturing facilities, and authorities have taken different approaches to address the pandemic, resume economic activity and vaccinate their populations. Because the vast majority of our products (such as oral care products, soaps and other personal hygiene products, home cleaners and pet food) have been deemed essential for the health and well-being of people and their pets, we have, in most instances, been able to continue operating our business.

In doing so, the health, safety and well-being of our employees has been and remains our first priority. Many of our employees globally continue to work from home. In those instances where our employees cannot perform their work at home, such as in our factories and in certain of our laboratories, or in geographies where circumstances have allowed us to offer employees the ability to return to the office, often on a voluntary and staggered basis, we have implemented additional health and safety measures and social distancing protocols, consistent with government recommendations and/or requirements, to help to ensure their safety, often at an additional cost. In addition, during the COVID-19 pandemic, we have experienced some limited factory closures and, in some cases, we have seen increased instances of absenteeism. Furthermore, some of our suppliers, customers, distributors, logistics providers and service providers have experienced disruptions to their businesses.

We saw a significant increase in demand across many of our categories such as liquid hand soap, dish liquid, bar soap and cleaners, during 2020 as a result of the COVID-19 pandemic, driven by consumer pantry-loading and increased consumption of our products. While during the quarter ended March 31, 2021 consumer demand for these categories softened, it remained above historical levels, and we believe that some of this increase in consumption is sustainable in light of changes in consumer behavior related to COVID-19. Across our business, changes in consumer demand for our products vary by product category and geography depending on, among other things, the severity of the COVID-19 outbreak and retailer availability. At the same time, during the COVID-19 pandemic, we have experienced declines in certain channels, including professional sales and travel retail, due to the economic slowdown and restricted consumer movement in many geographies throughout the world. We also continue to see changes in the purchasing patterns of our consumers, including the nature and/or frequency of visits by consumers to retailers and dental, veterinary and skin health professionals and a shift in many markets to purchasing our products online. In some instances during the COVID-19 pandemic, we were not able to keep up with the increased consumer demand for our products, and our products were at times out of stock on retailers’ shelves. In some cases, we have incurred additional costs as we worked to meet this increased demand.

COVID-19 and government steps to reduce the spread and address the impact of COVID-19 have impacted and may continue to impact our consumers’ ability to purchase and our ability to manufacture and distribute our products. While we believe that, in the long-term, consumer demand for the products in our categories will continue to be strong, uncertainties continue surrounding the timing and extent of the pandemic and the recovery from it. These uncertainties include: the impact of the timing and scale of changes to travel and movement restrictions in certain geographies, the availability and widespread distribution and use of safe and effective COVID-19 vaccines and when communities will reach herd immunity, the emergence and spread of COVID-19 variants, the timing and impact of consumer pantry-loading and destocking activity in certain markets, product demand trends and the impact of COVID-19 on the global economy. Our retail customers, contract manufacturers, logistics providers and other third parties are also being impacted by the global pandemic; their success in addressing COVID-19 and maintaining their operations could impact consumer access to and sales of our products. We expect the ongoing economic impact and health concerns associated with COVID-19 to continue to impact consumer behavior, shopping patterns and consumption preferences despite the lifting of government restrictions and the reopening of economies around the world.

21
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

While we currently expect to be able to continue operating our business as described above and we intend to continue to work with government authorities and to follow the necessary protocols to maintain the health and safety of our employees and contract providers, uncertainty resulting from COVID-19 could result in an unforeseen additional disruption to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.

For more information about the anticipated COVID-19 impact, see “Outlook” below.

















































22
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Business Strategy

To achieve our business and financial objectives, we are focused on innovating our core businesses; improving our brand building activities with an elevated brand purpose model and the use of equity advertising; innovating to gain market share in high growth segments and adjacencies; expanding into new channels and markets; maximizing growth online; and investing to drive consumption in growing populations. We continue to develop initiatives to build strong relationships with consumers, dental, veterinary and skin health professionals and traditional and eCommerce retailers. In addition, we continue to invest behind our brands, not just in terms of advertising, but also to build key growth capabilities in areas such as innovation and data and analytics. We also continue to broaden our eCommerce offerings, including direct-to-consumer and subscription services. We continue to believe that growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for our products. We are also working to integrate our sustainability and social impact and diversity, equity and inclusion strategies across our organization.

We are also changing the way we work to drive growth and how we approach innovation to respond to the dynamic retail landscape and the evolving preferences of our customers and consumers. The retail landscape, the ease of new entrants into the market in many of our categories and the evolving preferences of our customers and consumers demand that we work differently and faster in an agile, authentic and culturally relevant manner to drive innovation.

The investments needed to drive growth are supported by strong cash flow performance and our disciplined capital allocation strategy. These investments are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as our funding-the-growth initiatives, we seek to become even more effective and efficient throughout our businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. We also continue to prioritize our investments in high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses, including by expanding our portfolio in premium skin health.

Significant Items Impacting Comparability

On January 31, 2020, we acquired Hello Products LLC (“hello”), an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of our strategy to focus on high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses. See Note 4, Acquisitions to the Condensed Consolidated Financial Statements for additional information.

The provision for income taxes for the three months ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described in “Results of Operations-Income Taxes,” and in Note 10, Income Taxes to the Condensed Consolidated Financial Statements, both items were previously recorded in connection with the charge recorded in 2017 and revised in 2018 related to the Tax Cuts and Jobs Act (the “TCJA”).













23
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Outlook

Looking forward, we expect global macroeconomic, political and market conditions to remain challenging, especially due to COVID-19. During the first year of the COVID-19 pandemic, we saw improvement in category growth rates due to heightened demand for certain health and hygiene products, particularly liquid hand soap, dish liquid, bar soap and cleaners. We believe some of this increased consumption is sustainable due to consumer behavior changes related to COVID-19. However, we expect increased volatility across all of our categories and it is therefore difficult to predict category growth rates in the near term.

While the global marketplace in which we operate has always been highly competitive, we continue to experience heightened competitive activity in certain markets from strong local competitors, from other large multinational companies, some of which have greater resources than we do, and from new entrants into the market in many of our categories. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. We have seen increases in promotional activities in certain markets as retailers try aggressively to get consumers back into the stores as prolonged “stay at home” and other government restrictions ease, a trend we expect will continue. We have been negatively affected by changes in the policies or practices of our retail trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space, delisting of our products or sustainability, supply chain or packaging initiatives. In addition, the retail landscape in many of our markets continues to evolve as a result of the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. These trends have been magnified due to COVID-19 in many of our geographies and we plan to continue to invest behind our eCommerce capabilities. This rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers. In certain markets, we have incurred and are likely to continue to incur increased logistics costs due to higher eCommerce demand and volume and capacity constraints in the shipping and logistics industry. In addition, given that approximately 70% of our Net sales originate in markets outside the U.S., we have experienced and will likely continue to experience volatile foreign currency fluctuations and higher raw and packaging material costs. While we have taken, and will continue to take, measures to mitigate the effect of these conditions, in the current environment, it may become increasingly difficult to implement certain of these mitigation strategies. Should these conditions persist, they could adversely affect our future results.

As discussed above, we continue to closely monitor the impact of COVID-19 on our business. While we have taken, and will continue to take, measures to mitigate the effects of COVID-19, we cannot estimate with certainty the full extent of COVID-19’s impact on our business, results of operations, cash flows and/or financial condition. For more information about factors that could impact our business, including due to COVID-19, see “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020.

In summary, we believe that we are well prepared to meet the challenges ahead due to our strong financial condition, broad based experience operating in challenging environments, resilient global supply chain and focused business strategy. Our strategy is based on driving organic sales growth through innovation within our core businesses, leveraging faster growth in adjacent categories and expanding in high-growth channels and markets; delivering margin expansion through operating leverage and efficiency; and maximizing the impact of our environmental, social and governance programs and leading in the development of human capital, including our sustainability and social impact and diversity, equity and inclusion strategies. Our commitment to these priorities, the strength of our brands, the breadth of our global footprint and a commitment to driving efficiency in cash generation should position us well to manage through COVID-19 and increase shareholder value over time.








24
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Results of Operations

Three Months

Worldwide Net sales were $4,344 in the first quarter of 2021, up 6.0% from the first quarter of 2020, due to volume growth of 0.5%, net selling price increases of 4.5% and positive foreign exchange of 1.0%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 5.0% in the first quarter of 2021. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,558 in the first quarter of 2021, up 5.5% from the first quarter of 2020, due to net selling price increases of 4.5% and positive foreign exchange of 1.0%, while volume remained flat. Organic sales in the Oral, Personal and Home Care product segment increased 4.5% in the first quarter of 2021.

The Company’s share of the global toothpaste market was 39.2% on a year-to-date basis, down 1.1 share points from the year ago period, and its share of the global manual toothbrush market was 30.6% on a year-to-date basis, down 0.7 share points from the year ago period. Year-to-date market shares in toothpaste were up in North America and Africa/Eurasia and down in Latin America, Europe and Asia Pacific versus the comparable 2020 period. In the manual toothbrush category, year-to-date market shares were up in Latin America and Africa/Eurasia and down in North America, Europe and Asia Pacific versus the comparable 2020 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $786 in the first quarter of 2021, up 9.5% from the first quarter of 2020, due to volume growth of 3.0%, net selling price increases of 4.0% and positive foreign exchange of 2.5%. Organic sales in the Hill’s Pet Nutrition segment increased 7.0% in the first quarter of 2021.

25
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Gross Profit/Margin

Worldwide Gross profit increased to $2,637 in the first quarter of 2021 from $2,465 in the first quarter of 2020. Gross profit in the first quarter of 2020 included acquisition-related costs. Excluding acquisition-related costs in the first quarter of 2020, Gross profit increased to $2,637 in the first quarter of 2021 from $2,469 in the first quarter of 2020, reflecting an increase of $150 resulting from higher Net sales and an increase of $18 resulting from higher Gross profit margin.

Worldwide Gross profit margin increased to 60.7% in the first quarter of 2021 from 60.2% in the first quarter of 2020. Excluding acquisition-related costs in the first quarter of 2020, Gross profit margin increased by 40 basis points (bps) to 60.7% in the first quarter of 2021 from 60.3% in the first quarter of 2020. This increase in Gross profit margin was primarily due to cost savings from the Company’s funding-the-growth initiatives (180 bps) and higher pricing (170 bps), partially offset by significantly higher raw and packaging material costs (310 bps), which included foreign exchange transaction costs.
Three Months Ended March 31,
20212020
Gross profit, GAAP$2,637 $2,465 
Acquisition-related costs— 4 
Gross profit, non-GAAP$2,637 $2,469 
Three Months Ended March 31,
20212020Basis Point Change
Gross profit margin, GAAP60.7 %60.2 %50 
Acquisition-related costs— 0.1 
Gross profit margin, non-GAAP60.7 %60.3 %40 
26
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 9% to $1,605 in the first quarter of 2021 from $1,473 in the first quarter of 2020, reflecting higher overhead expenses of $81 and increased advertising investment of $51.

Selling, general and administrative expenses as a percentage of Net sales increased 90 bps to 36.9% in the first quarter of 2021 from 36.0% in the first quarter of 2020. This increase was due to increased advertising investment (50 bps) and higher overhead expenses (40 bps), primarily driven by higher logistics costs, both as a percentage of Net sales. In the first quarter of 2021, advertising investment increased as a percentage of Net sales to 12.3% from 11.8% in the first quarter of 2020, or 11% in absolute terms to $535 as compared with $484 in the first quarter of 2020.
Three Months Ended March 31,
20212020
Selling, general and administrative expenses$1,605 $1,473 
Three Months Ended March 31,
20212020Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales36.9 %36.0 %90
27
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Operating Profit

Operating profit increased 5% to $1,004 in the first quarter of 2021 from $952 in the first quarter of 2020. Operating profit in the first quarter of 2020 included acquisition-related costs. Excluding acquisition-related costs in the first quarter of 2020, Operating profit increased to $1,004 in the first quarter of 2021 from $958 in the first quarter of 2020, as an increase in Gross profit was partially offset by an increase in Selling, general and administrative expenses.

Operating profit margin was 23.1% in the first quarter of 2021, a decrease of 10 bps compared to 23.2% in the first quarter of 2020. Excluding acquisition-related costs in the first quarter of 2020, Operating profit margin was 23.1% in the first quarter of 2021, a decrease of 30 bps compared to 23.4% in the first quarter of 2020. This decrease in Operating profit margin was primarily due to an increase in Selling, general and administrative expenses (90 bps), partially offset by an increase in Gross profit (40 bps), both as a percentage of Net sales.
Three Months Ended March 31,
20212020% Change
Operating profit, GAAP$1,004 $952 5 %
Acquisition-related costs— 6 
Operating profit, non-GAAP$1,004 $958 5 %
Three Months Ended March 31,
20212020Basis Point Change
Operating profit margin, GAAP23.1 %23.2 %(10)
Acquisition-related costs
— 0.2 
Operating profit margin, non-GAAP23.1 %23.4 %(30)
Non-Service Related Postretirement Costs

Non-service related postretirement costs were $18 in the first quarter of 2021, as compared to $21 in the first quarter of 2020.
Interest (Income) Expense, Net

Interest (income) expense, net was $29 in the first quarter of 2021 as compared to $36 in the first quarter of 2020, primarily due to lower average interest rates on debt.
28
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Income Taxes

The effective income tax rate was 23.9% for the first quarter of 2021 as compared to 16.4% for the first quarter of 2020. As reflected in the table below, the non-GAAP effective income tax rate was 23.9% for the quarter ended March 31, 2021, as compared to 24.4% in the comparable period of 2020.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 24.0%, compared to 24.7% in the first quarter of 2020. See Note 10, Income Taxes to the Condensed Consolidated Financial Statements for additional details.
Three Months Ended March 31,
20212020
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
As Reported GAAP$957 $229 23.9 %$895 $147 16.4 %
Subsidiary and operating structure initiatives — — — — 71 7.9 
Acquisition-related costs— — — 6 2 0.1 
Non-GAAP$957 $229 23.9 %$901 $220 24.4 %

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

The provision for income taxes for the three months ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the TCJA.

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes would be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes in the first quarter of 2020.

Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, reversed the previously recorded valuation allowance of $26 in the first quarter of 2020.



29
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company in the first quarter of 2021 decreased to $681 from $715 in the first quarter of 2020, and Earnings per common share on a diluted basis decreased to $0.80 per share in the first quarter of 2021 from $0.83 in the first quarter of 2020. Net income attributable to Colgate-Palmolive Company in the first quarter of 2020 included acquisition-related costs and a benefit related to subsidiary and operating structure initiatives.

Excluding the items described above in the first quarter of 2020, Net income attributable to Colgate-Palmolive Company in the first quarter of 2021 increased 5% to $681 from $648 in the first quarter of 2020, and Earnings per common share on a diluted basis increased 7% to $0.80 in the first quarter of 2021 from $0.75 in the first quarter of 2020.
Three Months Ended March 31, 2021
Income Before Income TaxesProvision For Income TaxesNet Income Including Noncontrolling InterestsNet Income Attributable To Colgate-Palmolive CompanyDiluted Earnings Per Share
As Reported GAAP$957 $229 $728 $681 $0.80 
Three Months Ended March 31, 2020
Income Before Income Taxes
Provision For Income Taxes(1)
Net Income Including Noncontrolling InterestsNet Income Attributable To Colgate-Palmolive Company
Diluted Earnings Per Share(2)
As Reported GAAP$895 $147 $748 $715 $0.83 
Subsidiary and operating structure initiatives— 71 (71)(71)(0.08)
Acquisition-related costs6 2 4 4 — 
Non-GAAP$901 $220 $681 $648 $0.75 
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
30
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America
Three Months Ended March 31,
 20212020Change
Net sales$923 $929 (0.5)%
Operating profit$202 $258 (22)%
% of Net sales21.9 %27.8 %(590)bps
Net sales in North America decreased 0.5% in the first quarter of 2021 to $923 as volume declines of 6.5% were partially offset by net selling price increases of 5.5% and positive foreign exchange of 0.5%. The Company’s acquisition of hello contributed 0.5% to volume in North America. Organic sales in North America decreased 1.5% in the first quarter of 2021. An organic sales decline in the United States was partially offset by organic sales growth in Canada.

The decrease in organic sales in North America in the first quarter of 2021 versus the first quarter of 2020 was primarily due to a decrease in Personal Care organic sales. The decrease in Personal Care was primarily due to organic sales declines in the bar soap, underarm protection and liquid hand soap categories partially offset by organic sales growth in the skin health category.
Operating profit in North America decreased 22% in the first quarter of 2021 to $202, or 590 bps to 21.9% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to increases in Selling, general and administrative expenses (390 bps) and a decrease in Gross profit (210 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (510 bps), partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives (140 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (280 bps), primarily driven by higher logistics costs, and increased advertising investment (110 bps).

Latin America
Three Months Ended March 31,
 20212020Change
Net sales$907 $889 2.0 %
Operating profit$272 $248 10 %
% of Net sales30.0 %27.9 %210 bps
Net sales in Latin America increased 2.0% in the first quarter of 2021 to $907, as volume growth of 1.0% and net selling price increases of 8.5% were partially offset by negative foreign exchange of 7.5%. Organic sales in Latin America increased 9.5% in the first quarter of 2021. Organic sales growth was led by Brazil, Mexico, Argentina and Colombia.

The increase in organic sales in Latin America in the first quarter of 2021 versus the first quarter of 2020 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste, manual toothbrush and mouthwash categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and liquid hand soap categories. The increase in Home Care was primarily due to organic sales growth in the fabric softener, liquid cleaner and hand dish categories.

31
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Operating profit in Latin America increased 10% in the first quarter of 2021 to $272, or 210 bps to 30.0% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (180 bps), partially offset by an increase in Selling, general and administrative expenses (80 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (330 bps), partially offset by higher raw and packaging material costs (490 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expense was due to higher overhead expenses (120 bps), partially offset by decreased advertising investment (40 bps).
 
Europe
 Three Months Ended March 31,
 20212020Change
Net sales$717 $675 6.0 %
Operating profit$180 $154 17 %
% of Net sales25.1 %22.8 %230 bps
Net sales in Europe increased 6.0% in the first quarter of 2021 to $717 due to net selling price increases of 1.5% and positive foreign exchange of 8.0%, partially offset by volume declines of 3.5%. Organic sales in Europe decreased 2.0% in the first quarter of 2021. Organic sales declines in Germany and the United Kingdom were partially offset by organic sales growth in the Nordic region and Switzerland.

The decrease in organic sales in Europe in the first quarter of 2021 versus the first quarter of 2020 was due to decreases in Oral Care, Personal Care and Home Care organic sales. The decrease in Oral Care was primarily due to organic sales declines in the toothpaste category, partially offset by organic sales growth in the mouthwash category. The decrease in Personal Care was primarily due to organic sales declines in the bar soap, body wash and underarm protection categories, partially offset by organic sales growth in the skin health category. The decrease in Home Care was primarily due to organic sales declines in the bleach and liquid cleaner categories.

Operating profit in Europe increased 17% in the first quarter of 2021 to $180, or 230 bps to 25.1% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (100 bps) and a decrease in Selling, general and administrative expenses (80 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (160 bps), higher pricing and favorable mix (40 bps), partially offset by higher raw and packaging material costs (140 bps). This decrease in Selling, general and administrative expenses was primarily due to lower overhead expenses (70 bps).

Asia Pacific
 Three Months Ended March 31,
 20212020Change
Net sales$739 $633 16.5 %
Operating profit$224 $161 39 %
% of Net sales30.3 %25.4 %490 bps
Net sales in Asia Pacific increased 16.5% in the first quarter of 2021 to $739 due to volume growth of 10.5%, selling price increases of 0.5% and positive foreign exchange of 5.5%. Organic sales in Asia Pacific increased 11.0% in the first quarter of 2021. Organic sales growth was led by the Greater China region, India, the Philippines and Thailand.

The increase in organic sales in Asia Pacific in the first quarter of 2021 versus the first quarter of 2020 was due to an increase in Oral Care organic sales. The increase in Oral Care was primarily due to increases in organic sales in the toothpaste and manual toothbrush categories.





32
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Operating profit in Asia Pacific increased 39% in the first quarter of 2021 to $224, or 490 bps to 30.3% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (320 bps) and a decrease in Selling, general and administrative expenses (160 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (170 bps), lower manufacturing costs (70 bps) primarily related to benefits of higher manufacturing volume, higher pricing and lower raw and packaging material costs (10 bps). This decrease in Selling, general and administrative expenses was primarily due to lower overhead expenses (150 bps).

Africa/Eurasia
 Three Months Ended March 31,
 20212020Change
Net sales$272 $252 8.5 %
Operating profit$54 $56 (4)%
% of Net sales19.9 %22.2 %(230)bps
Net sales in Africa/Eurasia increased 8.5% in the first quarter of 2021 to $272, as volume growth of 5.0% and net selling price increases of 8.0% were partially offset by negative foreign exchange of 4.5%. Organic sales in Africa/Eurasia increased 13.0% in the first quarter of 2021. Organic sales growth was led by Turkey, Nigeria, South Africa and Russia.

The increase in organic sales in Africa/Eurasia in the first quarter of 2021 versus the first quarter of 2020 was primarily due to an increase in Oral Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories.

Operating profit in Africa/Eurasia decreased 4% in the first quarter of 2021 to $54, or 230 bps to 19.9% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit (160 bps) and an increase in Selling, general and administrative expenses (70 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (610 bps), which included foreign exchange transaction costs, partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives (160 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (190 bps), primarily driven by higher logistics costs, partially offset by decreased advertising investment (120 bps).
























33
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Hill’s Pet Nutrition
 Three Months Ended March 31,
 20212020Change
Net sales$786 $719 9.5 %
Operating profit$215 $203 6 %
% of Net sales27.4 %28.2 %(80)bps
Net sales for Hill’s Pet Nutrition increased 9.5% in the first quarter of 2021 to $786 due to volume growth of 3.0%, net selling price increases of 4.0% and positive foreign exchange of 2.5%. Organic sales in Hill’s Pet Nutrition increased 7.0% in the first quarter of 2021. Organic sales growth was led by the United States, Europe and Canada.

The increase in organic sales in the first quarter of 2021 was primarily due to organic sales growth in the Science Diet and Prescription Diet categories.

Operating profit in Hill’s Pet Nutrition increased 6% in the first quarter of 2021 to $215, while as a percentage of Net sales it decreased 80 bps to 27.4%. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (40 bps) and an increase in Selling, general and administrative expenses (20 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (230 bps), partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives (90 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (250 bps), partially offset by lower overhead expenses (230 bps).

During the quarter ended March 31, 2019, Hill’s announced a voluntary recall, which was subsequently expanded, of select canned dog food products due to potentially elevated levels of Vitamin D resulting from a supplier error. In the United States, the voluntary recall was conducted in cooperation with the U.S. Food and Drug Administration. Following the announcement of the voluntary recall, and as of March 31, 2021, Hill’s and/or the Company have been named as defendants in 37 putative class action lawsuits, one putative class action filed on behalf of a European Union class and one individual action, all related to the voluntary recall and filed in various jurisdictions in the United States. In addition, two putative class actions related to the voluntary recall have been filed in Canada. Eight of the putative class actions lawsuits in the United States and one of the putative class action lawsuits in Canada have been voluntarily dismissed. During the quarter ended December 31, 2020, the parties to the putative class action lawsuits in the United States (other than the class action filed on behalf of a European Union class) entered into a settlement agreement, which was preliminarily approved by the court in February 2021. The amount of the settlement is not material to the Company’s results of operations for the quarter ended March 31, 2021. Hill’s is indemnified by the supplier related to the voluntary recall. Sales of products voluntarily recalled represent less than 2% of Hill’s annual Net sales. The sales loss and other costs associated with the voluntary recall and its subsequent expansion did not have a material impact on the Company’s Net sales or Operating profit for the quarter ended March 31, 2021 and are not expected to have a material impact in future periods.

Corporate
 Three Months Ended March 31,
 20212020Change
Operating profit (loss)$(143)$(128)12 %
Operating profit (loss) related to Corporate was ($143) in the first quarter of 2021 as compared to ($128) in the first quarter of 2020. In the first quarter of 2020, Corporate Operating profit (loss) included acquisition-related costs of $6.

34
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the three months ended March 31, 2021 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Interest (income) expense, net, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding, as applicable, acquisition-related costs and a benefit related to a reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure implemented within one of the Company’s divisions. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisitions, divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three months ended March 31, 2021 and 2020 is presented within the applicable section of Results of Operations.

The following table provides a quantitative reconciliation of Net sales growth to organic sales growth for the three months ended March 31, 2021:
Three Months Ended March 31, 2021Net Sales Growth
(GAAP)		Foreign
Exchange
Impact		Acquisitions and Divestments
Impact		Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care    
North America(0.5)%0.5%0.5%(1.5)%
Latin America2.0%(7.5)%—%9.5%
Europe6.0%8.0%—%(2.0)%
Asia Pacific16.5%5.5%—%11.0%
Africa/Eurasia8.5%(4.5)%—%13.0%
Total Oral, Personal and Home Care5.5%1.0%—%4.5%
Pet Nutrition9.5%2.5%—%7.0%
Total Company6.0%1.0%—%5.0%


35
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, share repurchases and acquisitions). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations decreased 22% to $598 in the first three months of 2021, compared with $768 in the comparable period of 2020, primarily due to higher tax payments and higher working capital. The Company continues to be tightly focused on working capital. The Company’s working capital was (4.4%) as a percentage of Net sales as of March 31, 2021 as compared to (3.5%) as of March 31, 2020. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt).

Investing activities used $142 of cash in the first three months of 2021, compared with $459 in the comparable period of 2020. Investing activities in the first three months of 2020 included the Company’s acquisition of hello for cash consideration of $351. This acquisition was financed with a combination of debt and cash.

Capital spending was $107 in the first three months of 2021 compared to $82 in the comparable period of 2020. Capital expenditures for 2021 are expected to be approximately 3.0% to 3.5% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. 

Financing activities used $334 of cash during the first three months of 2021, compared with $308 used in the comparable period of 2020. This reflects higher share repurchases associated with the share repurchase program and lower proceeds from the exercise of stock options in the first three months of 2021 compared with the comparable period of 2020. This use of cash was partially offset by proceeds from the issuance of debt and increase in short-term borrowing in the first three months of 2021 compared with the comparable period of 2020. As previously disclosed, during the year ended December 31, 2020, the Company moderated its share repurchases, net of proceeds from the exercise of stock options, to reduce incremental debt levels related to acquisitions. During the first quarter of 2021, the Company's share repurchases, net returned to historical levels.

Long-term debt, including the current portion, increased to $7,579 as of March 31, 2021, as compared to $7,343 as of December 31, 2020, and total debt was $7,833 as of March 31, 2021, as compared to $7,601 as of December 31, 2020. The Company’s debt issuances support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital.

Domestic and foreign commercial paper outstanding was $1,716 and $858 as of March 31, 2021 and 2020, respectively. The average daily balances outstanding for commercial paper in the first three months of 2021 and 2020 were $1,903 and $1,694, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its unused lines of credit (including under the facilities discussed below) or by issuing long-term debt pursuant to an effective shelf registration statement. In November 2018, the Company entered into an amended and restated $2,650 revolving credit facility with a syndicate of banks that was scheduled to expire in November 2023. In August 2019, the term of the facility was extended by one year, and it now expires in November 2024. In August 2020, the Company entered into a $1,500 364-day credit facility with a syndicate of banks that is scheduled to expire in August 2021. Commitment fees related to the credit facilities are not material.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long term Debt and Credit Facilities, on the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for further information about the Company’s long-term debt and credit facilities.

In the first quarter of 2021, the Company increased the quarterly common stock dividend to $0.45 per share from $0.44 per share previously, effective in the second quarter of 2021.

36
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Cash and cash equivalents increased $107 during the first three months of 2021 to $995 at March 31, 2021, compared to $888 at December 31, 2020, the majority of which ($923 and $832, respectively) was held by the Company’s foreign subsidiaries.

During the three months ended March 31, 2021, COVID-19 did not have a significant impact on the Company’s liquidity for its continued operating and cash needs. For more information regarding the anticipated impact of COVID-19, see “Executive Overview” and “Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.






























37
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In certain limited circumstances, the COVID-19 pandemic has impacted the ability of our third-party vendors to provide the Company with reliable updated market share data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share levels, financial goals, the impact of foreign exchange volatility, the impact of COVID-19, cost-reduction plans, tax rates, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic and political environment in different countries and its effect on consumer spending habits, foreign currency rate fluctuations, exchange controls, tariffs, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, increased competition and evolving competitive practices (including from the growth of eCommerce and the entry of new competitors and business models), the ability to operate and respond effectively during a pandemic, epidemic or widespread public health concern, including COVID-19, ability to manage disruptions in our global supply chain and/or key office facilities, ability to manage the availability and cost of raw and packaging materials and logistics costs, the ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers, the emergence of alternative retail channels, the growth of eCommerce and the rapidly changing retail landscape (as consumers increasingly shop online), the ability to develop innovative new products, the ability to continue lowering costs and operate in an agile manner, the ability to maintain the security of our information technology systems from a cyber-security incident or data breach, the ability to address the effects of climate change and achieve our sustainability and social impact goals, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, the ability to attract and retain key employees and integrate diversity, equity and inclusion initiatives across our organization, the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit, and the ability to address uncertain or unfavorable global economic conditions, disruptions in the credit markets and tax matters. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q).

38
COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2020.

39



COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2021 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control Over Financial Reporting

The Company is in the process of upgrading its enterprise IT system to SAP S/4 HANA. This change has not had and is not expected to have a material impact on the Company’s internal controls over financial reporting.

Except as noted above, there were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.


40


COLGATE-PALMOLIVE COMPANY

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

For information regarding legal matters, please refer to Note 11, Contingencies to the Condensed Consolidated Financial Statements contained in Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Item 1A.    Risk Factors

There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.


41


COLGATE-PALMOLIVE COMPANY

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds    

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2021:
Month
Total Number of Shares Purchased(1)
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3)
(in millions)
January 1 through 31, 20211,500,733 $80.87 1,456,830 $1,711 
February 1 through 28, 20211,405,641 $78.18 1,348,000 $1,606 
March 1 through 31, 20211,777,283 $76.21 1,748,200 $1,472 
Total4,683,657 $78.29 4,553,030  

(1) Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.
(2)The difference between the total number of shares purchased and the total number of shares purchased as part of publicly
announced plans or programs is 130,627 shares, which represents shares deemed surrendered to the Company to satisfy
certain employee elections under the Company’s compensation and benefit programs.
(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of March 31, 2021.



Item 3.    Defaults Upon Senior Securities

None.


Item 4.    Mine Safety Disclosures

Not Applicable.


Item 5.    Other Information

None.

42


COLGATE-PALMOLIVE COMPANY


Item 6.    Exhibits
Exhibit No. Description
31-A 
   
31-B 
   
32 
   
101 The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2021, formatted in Inline eXtensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Changes in Shareholders’ Equity and (vi) Notes to Condensed Consolidated Financial Statements.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

__________
*    Filed herewith.

** Furnished herewith.

43

COLGATE-PALMOLIVE COMPANY
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 COLGATE-PALMOLIVE COMPANY
 (Registrant)
  
 Principal Executive Officer:
  
April 30, 2021/s/ Noel R. Wallace
 Noel R. Wallace
 Chairman of the Board, President and
Chief Executive Officer
  
 Principal Financial Officer:
  
April 30, 2021/s/ Stanley J. Sutula III
 Stanley J. Sutula III
 Chief Financial Officer
  
 Principal Accounting Officer:
  
April 30, 2021/s/ Philip G. Shotts
 Philip G. Shotts
 Vice President and Controller
44
 EX-31.A 2 exhibit31a_033121xq12021.htm EX-31.A Document

EXHIBIT 31-A

I, Noel R. Wallace, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: April 30, 2021
/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer


 EX-31.B 3 exhibit31b_033121xq12021.htm EX-31.B Document

EXHIBIT 31-B

I, Stanley J. Sutula III, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: April 30, 2021
/s/ Stanley J. Sutula III
Stanley J. Sutula III
Chief Financial Officer


 EX-32 4 exhibit32_033121xq12021.htm EX-32 Document

EXHIBIT 32
The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1)the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2)information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: April 30, 2021
/s/ Noel R. Wallace
Noel R. Wallace
Chairman of the Board, President and
Chief Executive Officer
/s/ Stanley J. Sutula III
Stanley J. Sutula III
Chief Financial Officer



 EX-101.SCH 5 cl-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - Use of Estimates link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - Use of Estimates (Policies) link:presentationLink link:calculationLink link:definitionLink 2104103 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2105104 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2109105 - Disclosure - Restructuring and Related Implementation Charges link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2111106 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2312302 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2114107 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2315303 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2416405 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2117108 - Disclosure - Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2318304 - Disclosure - Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2419406 - Disclosure - Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2120109 - Disclosure - Retirement Plans and Other Retiree Benefits link:presentationLink link:calculationLink link:definitionLink 2321305 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2422407 - Disclosure - Retirement Plans and Other Retiree Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2123110 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2424408 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2125111 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2426409 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2127112 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2328306 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2429410 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2430411 - Disclosure - Segment Information - Schedule of Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2131113 - Disclosure - Fair Value Measurements and Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2332307 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2433412 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2434413 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2435414 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2436415 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) link:presentationLink link:calculationLink link:definitionLink 2437416 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) link:presentationLink link:calculationLink link:definitionLink 2438417 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 cl-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 cl-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 cl-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Carrying value of long-term debt Long-term Debt Document Type Document Type Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Contingencies Commitments and Contingencies Disclosure [Text Block] Service cost Defined Benefit Plan, Service Cost 1.375% Notes Due 2034 1.375% Notes Due 2034 [Member] 1.375% Notes Due 2034 [Member] Treasury Stock Treasury Stock [Member] Accounts payable and other accruals Increase (Decrease) in Accounts Payable and Accrued Liabilities Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Customer Relationships Customer Relationships [Member] Business Segments [Axis] Segments [Axis] Equity Components [Axis] Equity Components [Axis] Gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Loss contingency, pending claims, number (in cases) Loss Contingency, Pending Claims, Number Retirement Plans and Other Retiree Benefits Retirement Benefits [Text Block] Finished goods Inventory, Finished Goods, Net of Reserves Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Minimum Minimum [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Proceeds from sale of marketable securities and investments Proceeds from Sale and Maturity of Marketable Securities Other current assets Other Current Assets [Member] Derivative assets Derivative Asset Europe Europe [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Less: Net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Personal Care Personal Care [Member] Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items. Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Schedule of gains (losses) recognized in Statements of Income Derivative Instruments, Gain (Loss) [Table Text Block] Deferred income taxes Deferred Income Tax Liabilities, Net Brazilian internal revenue authority, matter 2 Tax Assessments With Interest And Penalties The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary. Amortization of actuarial loss (gain) Defined Benefit Plan, Amortization of Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Schedule of derivative instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) United States UNITED STATES Security Exchange Name Security Exchange Name Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Commodity contracts Commodity Contracts Commodity Contract [Member] Fine imposed by Greek competition authority Fine Imposed By Greek Competition Authority Fine Imposed by Greek Competition Authority Africa/Eurasia Africa Eurasia [Member] A specified group of foreign regions about which segment information is provided by the entity. Operating profit Total operating profit Operating Income (Loss) Total current liabilities Liabilities, Current Entity Registrant Name Entity Registrant Name Accumulated other comprehensive loss, cumulative translation losses Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Business Acquisition [Line Items] Business Acquisition [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Less: Cumulative translation adjustments attributable to noncontrolling interests Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Shares issued for restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Provisional income tax benefit Discrete Income Tax Provision (Benefit) Discrete Income Tax Provision (Benefit) Purchases of treasury shares Payments for Repurchase of Common Stock Assets Assets [Abstract] Accounting Policies [Abstract] Accounting Policies [Abstract] Number of reportable segments (in segments) Number of Reportable Segments Retirement Plan Type [Domain] Retirement Plan Type [Domain] Entity Address, State or Province Entity Address, State or Province Other comprehensive income (loss), before tax Other comprehensive income (loss), pretax Other Comprehensive Income (Loss), before Tax Accounts payable Accounts Payable, Current Short-term borrowing (repayment) less than 90 days, net Proceeds from Other Short-term Debt Net income attributable to Colgate-Palmolive Company Earnings Per Share Reconciliation [Abstract] Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Consolidation Items [Axis] Consolidation Items [Axis] Forward-starting interest rate swaps Forward Contracts [Member] Loss contingency, claims previously dismissed, number affirmed on appeal Loss Contingency, Claims Previously Dismissed, Number Affirmed On Appeal Loss Contingency, Claims Previously Dismissed, Number Affirmed On Appeal Derivative and Financial Instruments, Fair Value [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Retained earnings Retained Earnings (Accumulated Deficit) Withholding tax due Withholding Tax Due Withholding Tax Due Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Receivables (net of allowances of $89 and $89, respectively) Accounts Receivable, after Allowance for Credit Loss, Current Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Other financial instruments Financial Instruments, Owned, at Fair Value [Abstract] International Foreign Plan [Member] Product Concentration Risk Product Concentration Risk [Member] Restructuring reserve Restructuring Reserve Income taxes paid Income Taxes Paid Shareholders’ Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Number of product segments (in segments) Number Of Product Segments Number of Product Segments Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trademarks Trademarks [Member] Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Payments for restructuring Payments for Restructuring Restructuring and termination benefits, net of cash Restructuring, net of cash The amount of noncash restructuring costs net of cash payments. Goodwill Goodwill Goodwill Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Document Transition Report Document Transition Report Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Marketable securities Marketable Securities Other liabilities Other Liabilities, Noncurrent Deferred income taxes Deferred Income Tax Assets, Net Other investing activities Payments for (Proceeds from) Other Investing Activities Liability Class [Axis] Liability Class [Axis] Domestic Plan Domestic Plan [Member] Work-in-process Inventory, Work in Process, Net of Reserves Dividends declared per common share (in dollars per share) Common Stock, Dividends, Per Share, Declared Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Effect of exchange rate changes on Cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents North America North America [Member] Other current assets Other Assets, Current Document Quarterly Report Document Quarterly Report Inventories Current Inventories, net Inventory, Net Net sales Total Net sales Revenue from Contract with Customer, Excluding Assessed Tax Percentage of consolidated Net sales represented by sales outside US Percentage Of Consolidated Net Sales Represented By Sales Outside US Percentage of Consolidated Net Sales represented by Sales outside US Components of net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Equity [Abstract] Equity [Abstract] Receivables Increase (Decrease) in Receivables Net investment hedges [Abstract] Summary of Net Investment Hedge Activity [Abstract] Percent of net sales Concentration Risk, Percentage Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Other liabilities Other Liabilities [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Entities [Table] Entities [Table] Statement [Line Items] Statement [Line Items] Recent Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Earnings per common share, basic (in dollars per share) Basic EPS (in dollars per share) Earnings Per Share, Basic Class of Stock [Domain] Class of Stock [Domain] Per Share Earnings Per Share, Basic and Diluted [Abstract] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Number of operating segments (in segments) Number of Operating Segments Entity File Number Entity File Number Gain (loss) on instruments Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Other accruals Other Current Liabilities [Member] Acquisition related costs Business Combination, Acquisition Related Costs Statement [Table] Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Interest cost Defined Benefit Plan, Interest Cost Restructuring Plan [Axis] Restructuring Plan [Axis] Estimated fair value of long-term debt Debt Instrument, Fair Value Disclosure Deferred income taxes Deferred Income Taxes and Tax Credits Home Care Home Care [Member] Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Dividends Dividends, Common Stock Hello Product LLC Hello Product LLC [Member] Hello Product LLC [Member] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] Accounting Standards Update and Change in Accounting Principle [Abstract] Carrying amount of hedged item Hedged Liability, Fair Value Hedge Balance Sheet Location [Axis] Balance Sheet Location [Axis] Amount reclassified from OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Business Combinations [Abstract] Business Combinations [Abstract] Common stock Common Stock, Value, Issued Long-term Debt Long-term Debt [Member] Document Fiscal Year Focus Document Fiscal Year Focus Entity Small Business Entity Small Business Other (income) expense, net Other Operating Income (Expense), Net Loss Contingency [Abstract] Loss Contingency [Abstract] Latin America Latin America [Member] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Changes in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Dividends paid Payments of Ordinary Dividends Gain (loss) on hedged items Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax 0.000% Notes due 2021 0.000% Notes due 2021 [Member] 0.000% Notes due 2021 [Member] Current portion of long-term debt Long-term Debt, Current Maturities Entity Current Reporting Status Entity Current Reporting Status Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Cost of sales Cost of Revenue Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Proceeds from issuance of debt Proceeds from Other Debt Retirement Benefits [Abstract] Retirement Benefits [Abstract] Amendment Flag Amendment Flag Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Total Comprehensive income including noncontrolling interests Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Shares (millions) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Corporate Corporate, Non-Segment [Member] Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other accruals Other Accrued Liabilities, Current Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Net cash provided by (used in) operations Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Restructuring and Related Implementation Charges Restructuring and Related Activities Disclosure [Text Block] Long-term debt Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Gains (losses) on cash flow hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Derivative Instrument [Axis] Derivative Instrument [Axis] Total Colgate-Palmolive Company shareholders’ equity Stockholders' Equity Attributable to Parent Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Total gain (loss) on hedges recognized in income Derivative, Gain (Loss) on Derivative, Net Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss contingency, claims dismissed or settled, number (in cases) Loss Contingency, Claims Settled and Dismissed, Number Purchase price consideration Business Combination, Consideration Transferred Fair Value Measurement [Domain] Fair Value Measurement [Domain] Total liabilities and equity Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Entity Address, City or Town Entity Address, City or Town Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Geographical [Axis] Geographical [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Oral Care Oral Care [Member] Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items. Interest (income) expense, net Interest (Income) Expense, Net [Member] Interest (Income) Expense, Net [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Other assets Other Assets [Member] Segments [Domain] Segments [Domain] Non-service related postretirement costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Cumulative hedging adjustment included in the carrying amount Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Equity Component [Domain] Equity Component [Domain] Unearned compensation Unearned Compensation Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Income Statement Location [Axis] Income Statement Location [Axis] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current 0.875% Notes due 2039 0.875% Notes due 2039 [Member] 0.875% Notes due 2039 [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Income Statement Location [Domain] Income Statement Location [Domain] Gross profit Gross Profit Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Property, plant and equipment, net Property, Plant and Equipment, Net Cash flow hedges [Abstract] Effect of Cash Flow Hedges on Results of Operations [Abstract] Selling, general and administrative expenses Selling, General and Administrative Expense Entity Tax Identification Number Entity Tax Identification Number Notional values Derivative, Notional Amount Schedule of notional values Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Foreign currency contracts Foreign Currency Contracts Foreign Exchange Contract [Member] Interest rate swap contracts Interest Rate Swaps Interest Rate Contract [Member] Net income attributable to Colgate-Palmolive Company Net Income (Loss) Attributable to Parent Cash effects of changes in: Increase (Decrease) in Operating Capital [Abstract] Loss contingency, number of cases resulting in adverse jury verdict Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number Other assets Other Assets, Noncurrent Inventories Inventory Disclosure [Text Block] Total Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Segment Information Segment Reporting Disclosure [Text Block] Unearned Compensation Unearned Compensation [Member] Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded. Total assets Assets Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Total Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Earnings Per Share [Abstract] Earnings Per Share [Abstract] Title of 12(b) Security Title of 12(b) Security Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Global Growth and Efficiency Program Global Growth and Efficiency Program [Member] Global Growth and Efficiency Program [Member] Accrued income taxes Accrued Income Taxes, Current Retirement plans and other retiree benefits adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Included in Operating profit (loss) Operating Income (Loss) [Member] Cost of sales Cost of Sales [Member] Other intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Total Inventories, net Inventory, Net, Including Noncurrent Inventory, Net, Including Noncurrent Other Stockholders' Equity, Other Depreciation and amortization Depreciation, Depletion and Amortization Product and Service [Axis] Product and Service [Axis] Designated derivative instruments Designated derivative instruments [Abstract] Designated derivative instruments [Abstract] Total liabilities Liabilities Diluted EPS Net Income (Loss) Available to Common Stockholders, Diluted Gain (loss) on derivative instrument Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Voluntary benefit plan contribution Defined Benefit Plan, Plan Assets, Contributions by Employer Supplemental Cash Flow Information Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Range of reasonably possible losses Loss Contingency, Estimate of Possible Loss Retirement Plan Type [Axis] Retirement Plan Type [Axis] Entity Filer Category Entity Filer Category Common Stock Common Stock [Member] Product and Service [Domain] Product and Service [Domain] Foreign withholding income tax Foreign Withholding Income Tax Foreign Withholding Income Tax Cumulative translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Percentage of consolidated Net sales coming from emerging markets Percentage Of Consolidated Net Sales Coming From Emerging Markets Percentage of Consolidated Net Sales coming from Emerging Markets Notes and loans payable Short-term Bank Loans and Notes Payable Basic EPS Net Income (Loss) Available to Common Stockholders, Basic Gain (loss) recognized in OCI Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Inventories Increase (Decrease) in Inventories Other non-current assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Valuation allowance against deferred tax asset Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Net Sales Revenue Benchmark [Member] Loss contingency, number of cases on appeal Loss Contingency, Number Of Cases On Appeal Loss Contingency, Number of Cases On Appeal Additional Paid-in Capital Additional Paid-in Capital [Member] Fair Value Hedges Fair Value Hedging [Member] Operating Segments Operating Segments [Member] Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Treasury stock acquired Treasury Stock, Value, Acquired, Cost Method Derivative liabilities Derivative Liability Oral, Personal and Home Care Oral, Personal and Home Care [Member] Oral, Personal and Home Care Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Net increase (decrease) in Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Acquisitions Business Combination Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Value Derivatives Balance Sheet Location [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Entity Information [Line Items] Entity Information [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] 0.500% Notes Due 2026 0.500% Notes Due 2026 [Member] 0.500% Notes Due 2026 [Member] Gain (loss) on hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Number of dividends declared per quarter Number Of Dividends Declared Per Quarter Number of Dividends Declared Per Quarter Basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Schedule of hedged item and cumulative adjustment to carrying amount Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Cumulative translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Cash Flow Hedges Cash Flow Hedging [Member] Loss Contingencies [Table] Loss Contingencies [Table] Payment for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Carrying Value Reported Value Measurement [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Stock options and restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Proceeds from exercise of stock options Proceeds from Stock Options Exercised Cost Property, Plant and Equipment, Gross Restructuring Plan [Domain] Restructuring Plan [Domain] Net Sales and Operating Profit by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Interest (income) expense, net Interest expense, net The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Additional paid-in capital Additional Paid in Capital Class of Stock [Axis] Class of Stock [Axis] Provision for income taxes Income Tax Expense (Benefit) Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Income (Loss) Total Other comprehensive income (loss) AOCI Attributable to Parent [Member] Cash and cash equivalents at beginning of the period Cash and cash equivalents at end of the period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Other assets and liabilities, net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net Schedule of gains (losses) included in Other Comprehensive Income Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block] Purchases of marketable securities and investments Payments to Acquire Marketable Securities Earnings per common share, diluted (in dollars per share) Diluted EPS (in dollars per share) Earnings Per Share, Diluted Local Phone Number Local Phone Number Retirement plans and other retiree benefit adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Reclassification from AOCI, pretax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Payments to acquire business Payments to Acquire Businesses, Gross Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Current Assets Assets, Current [Abstract] Brazilian internal revenue authority, matter 1 Tax Assessments With Interest The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition. Entity Address, Address Line One Entity Address, Address Line One Total other financial instruments Investments, Fair Value Disclosure Entity Emerging Growth Company Entity Emerging Growth Company Shares issued for stock options Stock Issued During Period, Value, Stock Options Exercised Total Comprehensive income attributable to Colgate-Palmolive Company Comprehensive Income (Loss), Net of Tax, Attributable to Parent Asia Pacific Asia Pacific [Member] Number of countries in which entity operates Number of Countries in which Entity Operates City Area Code City Area Code Consolidation Items [Domain] Consolidation Items [Domain] Maximum Maximum [Member] Noncontrolling Interests Noncontrolling Interest [Member] Document Period End Date Document Period End Date Retained Earnings Retained Earnings [Member] Measurement Basis [Axis] Measurement Basis [Axis] Pet Nutrition Pet Nutrition [Member] Pet Nutrition Net Investment Hedges Net Investment Hedging [Member] Loss contingency, new claims filed, number (in cases) Loss Contingency, New Claims Filed, Number Components Of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Use of Estimates Significant Accounting Policies [Text Block] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Net income including noncontrolling interests Net income including noncontrolling interests Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Reclassification from AOCI, net of tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Foreign Currency Debt Debt [Member] Other Retiree Benefits Other Postretirement Benefits Plan [Member] Trading Symbol Trading Symbol Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Inventories by Major Class Schedule of Inventory, Current [Table Text Block] Other comprehensive income (loss), before reclassifications, pretax Other Comprehensive Income (Loss), before Reclassifications, before Tax Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Capital expenditures Payments to Acquire Productive Assets Treasury stock, at cost Treasury Stock, Value Other financing activities Proceeds from (Payments for) Other Financing Activities Non-current inventory, net Inventory, Noncurrent Pension Benefits Pension Plan [Member] Earnings Per Share Earnings Per Share [Text Block] Cover [Abstract] Cover [Abstract] Inventory, Net, Items Net of Reserve Alternative [Abstract] Inventory, Net, Items Net of Reserve Alternative [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Fair Value Measurements and Financial Instruments Financial Instruments Disclosure [Text Block] Current Liabilities Liabilities, Current [Abstract] Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Other comprehensive income (loss), before reclassifications, net of tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Property, plant and equipment: Property, Plant and Equipment, Net [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 9 cl-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 cl-20210331_htm.xml IDEA: XBRL DOCUMENT 0000021665 2021-01-01 2021-03-31 0000021665 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000021665 cl:A0.000Notesdue2021Member 2021-01-01 2021-03-31 0000021665 cl:A0.500NotesDue2026Member 2021-01-01 2021-03-31 0000021665 cl:A1.375NotesDue2034Member 2021-01-01 2021-03-31 0000021665 cl:A0.875Notesdue2039Member 2021-01-01 2021-03-31 0000021665 2021-03-31 0000021665 2020-01-01 2020-03-31 0000021665 2020-12-31 0000021665 2019-12-31 0000021665 2020-03-31 0000021665 us-gaap:CommonStockMember 2020-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000021665 cl:UnearnedCompensationMember 2020-12-31 0000021665 us-gaap:TreasuryStockMember 2020-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-12-31 0000021665 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000021665 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0000021665 cl:UnearnedCompensationMember 2021-01-01 2021-03-31 0000021665 us-gaap:CommonStockMember 2021-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000021665 cl:UnearnedCompensationMember 2021-03-31 0000021665 us-gaap:TreasuryStockMember 2021-03-31 0000021665 us-gaap:RetainedEarningsMember 2021-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2021-03-31 0000021665 us-gaap:CommonStockMember 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000021665 cl:UnearnedCompensationMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000021665 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000021665 cl:UnearnedCompensationMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommonStockMember 2020-03-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000021665 cl:UnearnedCompensationMember 2020-03-31 0000021665 us-gaap:TreasuryStockMember 2020-03-31 0000021665 us-gaap:RetainedEarningsMember 2020-03-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-03-31 0000021665 cl:HelloProductLLCMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 2020-01-31 0000021665 srt:NorthAmericaMember cl:HelloProductLLCMember 2020-01-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2021-01-01 2021-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2021-03-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-12-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000021665 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000021665 srt:MinimumMember 2021-03-31 0000021665 srt:MaximumMember 2021-03-31 0000021665 2005-12-31 0000021665 2017-07-31 0000021665 2019-04-30 0000021665 2019-10-01 2019-12-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:EuropeMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:OralPersonalAndHomeCareMember 2020-01-01 2020-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2021-01-01 2021-03-31 0000021665 us-gaap:OperatingSegmentsMember cl:PetNutritionMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember 2021-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-03-31 0000021665 cl:OralCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-03-31 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-03-31 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-03-31 0000021665 cl:PetNutritionMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-03-31 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-03-31 0000021665 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2020-01-01 2020-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2021-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2021-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForwardContractsMember 2021-03-31 0000021665 us-gaap:OtherAssetsMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2021-03-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2021-03-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2021-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2021-03-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2021-03-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2021-03-31 0000021665 us-gaap:OtherCurrentAssetsMember 2020-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2021-03-31 0000021665 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-03-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000021665 us-gaap:LongTermDebtMember 2021-03-31 0000021665 us-gaap:LongTermDebtMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:ForwardContractsMember us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:FairValueHedgingMember 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:CashFlowHedgingMember 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:NetInvestmentHedgingMember 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:CommodityContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2021-01-01 2021-03-31 0000021665 us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000021665 cl:InterestIncomeExpenseNetMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForeignExchangeContractMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:ForwardContractsMember 2021-01-01 2021-03-31 0000021665 us-gaap:ForwardContractsMember 2020-01-01 2020-03-31 0000021665 us-gaap:CommodityContractMember 2021-01-01 2021-03-31 0000021665 us-gaap:CommodityContractMember 2020-01-01 2020-03-31 0000021665 us-gaap:DebtMember 2021-01-01 2021-03-31 0000021665 us-gaap:DebtMember 2020-01-01 2020-03-31 shares iso4217:USD iso4217:USD shares cl:Dividend cl:country_and_territory cl:case cl:segment pure 0000021665 --12-31 2021 Q1 false 10-Q true 2021-03-31 false 1-644 COLGATE-PALMOLIVE COMPANY DE 13-1815595 300 Park Avenue New York, NY 10022 212 310-2000 Common Stock, $1.00 par value CL NYSE 0.000% Notes due 2021 CL21A NYSE 0.500% Notes due 2026 CL26 NYSE 1.375% Notes due 2034 CL34 NYSE 0.875% Notes due 2039 CL39 NYSE Yes Yes Large Accelerated Filer false false false 845968780 4344000000 4097000000 1707000000 1632000000 2637000000 2465000000 1605000000 1473000000 -28000000 -40000000 1004000000 952000000 18000000 21000000 29000000 36000000 957000000 895000000 229000000 147000000 728000000 748000000 47000000 33000000 681000000 715000000 0.80 0.83 0.80 0.83 728000000 748000000 -158000000 -355000000 -2000000 -16000000 43000000 18000000 -113000000 -321000000 615000000 427000000 47000000 33000000 -3000000 -16000000 44000000 17000000 571000000 410000000 995000000 888000000 89000000 89000000 1402000000 1264000000 1676000000 1673000000 490000000 513000000 4563000000 4338000000 8637000000 8751000000 5028000000 5035000000 3609000000 3716000000 3701000000 3824000000 2787000000 2894000000 201000000 291000000 940000000 857000000 15801000000 15920000000 254000000 258000000 9000000 9000000 1306000000 1393000000 422000000 403000000 2548000000 2341000000 4539000000 4404000000 7570000000 7334000000 415000000 426000000 2614000000 2655000000 15138000000 14819000000 1466000000 1466000000 3011000000 2969000000 23624000000 23699000000 -4455000000 -4345000000 0 1000000 23384000000 23045000000 262000000 743000000 401000000 358000000 663000000 1101000000 15801000000 15920000000 728000000 748000000 137000000 133000000 -13000000 -30000000 38000000 16000000 6000000 -99000000 170000000 211000000 40000000 -29000000 -75000000 220000000 13000000 38000000 598000000 768000000 107000000 82000000 29000000 42000000 0 16000000 0 351000000 6000000 0 -142000000 -459000000 365000000 17000000 25000000 0 376000000 373000000 372000000 220000000 30000000 297000000 -6000000 -29000000 -334000000 -308000000 -15000000 -30000000 107000000 -29000000 888000000 883000000 995000000 854000000 227000000 128000000 1466000000 2969000000 -1000000 -23045000000 23699000000 -4345000000 358000000 681000000 47000000 -110000000 -3000000 0.89 756000000 38000000 13000000 22000000 -11000000 11000000 372000000 -2000000 -1000000 0 1000000 1466000000 3011000000 0 -23384000000 23624000000 -4455000000 401000000 1466000000 2488000000 -2000000 -22063000000 22501000000 -4273000000 441000000 715000000 33000000 -305000000 -16000000 0.87 738000000 4000000 16000000 133000000 164000000 -15000000 15000000 220000000 -1000000 -1000000 -3000000 1466000000 2623000000 -1000000 -22104000000 22481000000 -4578000000 454000000 -3313000000 -3467000000 -3158000000 -3128000000 1176000000 1122000000 1178000000 1138000000 2 2 Basis of Presentation <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission (the “SEC”).</span></div> Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable. Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable. Recent Accounting Pronouncements <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-01, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div> Recent Accounting Pronouncements <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-01, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.</span></div> Acquisitions <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hello Products LLC (“hello”)</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:10pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:87.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships, valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.</span></div> 351000000 <div style="margin-bottom:10pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:87.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 351000000 11000000 13000000 4000000 160000000 171000000 351000000 115000000 P25Y 45000000 P17Y 171000000 Restructuring and Related Implementation Charges <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">    </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019 and no new restructuring projects were approved for implementation subsequent to the conclusion of the Global Growth and Efficiency Program.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended March 31, 2021 and March 31, 2020, the Company made cash payments of $13 and $30, respectively, related to projects approved prior to the conclusion of the Global Growth and Efficiency Program.</span></div>The accrual balance at March 31, 2021 and December 31, 2020 was $19 and $31, respectively. 13000000 30000000 19000000 31000000 Inventories <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories by major class are as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"><tr><td style="width:1.0%"/><td style="width:67.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.296%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">       Total Inventories, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">            Non-current inventory, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">              Current Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories by major class are as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"><tr><td style="width:1.0%"/><td style="width:67.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.296%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">       Total Inventories, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">            Non-current inventory, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">              Current Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 463000000 454000000 48000000 45000000 1264000000 1256000000 1775000000 1755000000 99000000 82000000 1676000000 1673000000 Earnings Per Share <div style="margin-bottom:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, earnings per share were as follows:</span></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:19.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,721,084 and 20,965,110, respectively.</span></div> <div style="margin-bottom:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, earnings per share were as follows:</span></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:19.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Colgate-Palmolive Company</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 681000000 848600000 0.80 715000000 856900000 0.83 2800000 1500000 681000000 851400000 0.80 715000000 858400000 0.83 2721084 20965110 Other Comprehensive Income (Loss) <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:46.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retirement plans and other retiree benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain (loss) and prior service costs arising during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss, transition and prior service costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement plans and other retiree benefits adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of (gains) losses into net earnings on cash flow hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.</span></div><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.</span></div> <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:46.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.862%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retirement plans and other retiree benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain (loss) and prior service costs arising during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss, transition and prior service costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement plans and other retiree benefits adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of (gains) losses into net earnings on cash flow hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.</span></div><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.</span></div> -99000000 -155000000 -320000000 -339000000 -19000000 -14000000 2000000 1000000 -22000000 -16000000 -17000000 -15000000 3000000 2000000 19000000 16000000 53000000 41000000 25000000 20000000 -3000000 -2000000 3000000 2000000 56000000 43000000 22000000 18000000 -40000000 -110000000 -279000000 -305000000 Retirement Plans and Other Retiree Benefits <div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of Net periodic benefit cost for the three months ended March 31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:34.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Retiree Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, the Company made no voluntary contributions to its U.S. postretirement plans.</span></div> <div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of Net periodic benefit cost for the three months ended March 31, 2021 and 2020 were as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:34.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Retiree Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 4000000 4000000 6000000 6000000 15000000 19000000 5000000 5000000 9000000 11000000 27000000 27000000 6000000 4000000 0 0 -13000000 -11000000 -3000000 -1000000 -6000000 -5000000 1000000 3000000 6000000 6000000 21000000 22000000 0 0 Income Taxes <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TCJA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes would be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, in the first quarter of 2020, reversed $45 of previously recorded foreign withholding taxes.</span></div>Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, in the first quarter of 2020, reversed the previously recorded valuation allowance of $26. -71000000 -45000000 -26000000 0 -45000000 -26000000 Contingencies <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $400 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Brazilian Matters</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seller</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $103. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. </span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously. </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $45, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Competition Matter</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of March 31, 2021 of such competition law matters pending against the Company during the three months ended March 31, 2021 is set forth below.</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Talcum Powder Matters</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2021, there were 147 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 137 cases as of December 31, 2020. During the three months ended March 31, 2021, 14 new cases were filed and three cases were resolved by voluntary dismissal. In addition, during the three months ended March 31, 2021, the Company won an appeal in one case that, in 2019, resulted in a jury verdict in favor of the Company and, since all of the plaintiff’s appeals have been exhausted, the case is now closed. There were no settlements of pending cases in the three months ended March 31, 2021. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes a portion of such costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ERISA Matter</span></div>In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit. 200 0 400000000 103000000 5 45000000 11000000 10500000 147 137 14 3 1 1 Segment Information <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by segment were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.397%"><tr><td style="width:1.0%"/><td style="width:72.792%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.559%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit by segment was as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.397%"><tr><td style="width:1.0%"/><td style="width:72.792%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.559%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>For the three months ended March 31, 2020, Corporate Operating profit (loss) included acquisition-related costs of $6. 2 5 5 <div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by segment were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,097 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.397%"><tr><td style="width:1.0%"/><td style="width:72.792%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.559%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net sales</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit by segment was as follows:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.397%"><tr><td style="width:1.0%"/><td style="width:72.792%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.558%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.559%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral, Personal and Home Care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Africa/Eurasia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Oral, Personal and Home Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 923000000 929000000 907000000 889000000 717000000 675000000 739000000 633000000 272000000 252000000 3558000000 3378000000 786000000 719000000 4344000000 4097000000 0.70 0.45 0.45 0.44 0.19 0.20 0.18 0.18 0.18 0.18 1 1 202000000 258000000 272000000 248000000 180000000 154000000 224000000 161000000 54000000 56000000 932000000 877000000 215000000 203000000 -143000000 -128000000 1004000000 952000000 6000000 Fair Value Measurements and Financial Instruments <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2021 and December 31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.182%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.749%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated derivative instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total designated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of March 31, 2021 and December 31, 2020. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2021 and December 31, 2020, was $8,097 and $8,175, respectively, and the related carrying value was $7,579 and $7,343, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:56.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative hedging adjustment included in the carrying amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the notional values as of:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"/><td style="width:30.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of sales </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate swaps designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total gain (loss) on hedges recognized in income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of unrealized gains (losses) included in OCI:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:61.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.084%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-starting interest rate swaps designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency debt designated as net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total unrealized gain (loss) on hedges recognized in OCI</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2021 and December 31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.182%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.749%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.890%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 10pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated derivative instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total designated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 11000000 14000000 0 0 51000000 5000000 0 0 13000000 7000000 55000000 93000000 2000000 3000000 0 0 77000000 29000000 55000000 93000000 62000000 37000000 62000000 37000000 8097000000 8175000000 7579000000 7343000000 <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:56.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative hedging adjustment included in the carrying amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 411000000 413000000 11000000 14000000 <div style="margin-bottom:6pt;margin-top:15pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the notional values as of:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Debt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-Starting Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Hedges </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Hedges </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 527000000 0 400000000 0 0 927000000 825000000 0 0 600000000 19000000 1444000000 604000000 4164000000 0 0 0 4768000000 589000000 0 400000000 0 0 989000000 854000000 0 0 300000000 17000000 1171000000 528000000 4523000000 0 0 0 5051000000 <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"/><td style="width:30.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of sales </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate swaps designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as fair value hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total gain (loss) on hedges recognized in income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 2000000 0 0 -12000000 0 0 -2000000 0 0 12000000 0 0 0 0 24000000 0 0 0 0 0 -24000000 0 -6000000 0 0 2000000 0 0 3000000 0 0 1000000 0 0 -3000000 0 0 3000000 0 0 <div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and amount of unrealized gains (losses) included in OCI:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"/><td style="width:61.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.084%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-starting interest rate swaps designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commodity contracts designated as cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency contracts designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency debt designated as net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on hedged items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total unrealized gain (loss) on hedges recognized in OCI</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6000000 25000000 46000000 0 1000000 0 23000000 25000000 -23000000 -25000000 211000000 65000000 -211000000 -65000000 53000000 25000000 Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,313 at March 31, 2021 ($3,467 at March 31, 2020) and $3,158 at December 31, 2020 ($3,128 at December 31, 2019), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,176 at March 31, 2021 ($1,122 at March 31, 2020) and $1,178 at December 31, 2020 ($1,138 at December 31, 2019), respectively. Two dividends were declared in each of the first quarters of 2021 and 2020. XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover Page
 3 Months Ended
Mar. 31, 2021
shares
Entity Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2021
Document Transition Report false
Entity File Number 1-644
Entity Registrant Name COLGATE-PALMOLIVE COMPANY
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 13-1815595
Entity Address, Address Line One 300 Park Avenue
Entity Address, City or Town New York,
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10022
City Area Code 212
Local Phone Number 310-2000
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 845,968,780
Entity Central Index Key 0000021665
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2021
Document Fiscal Period Focus Q1
Amendment Flag false
Common Stock  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value
Trading Symbol CL
Security Exchange Name NYSE
0.000% Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Notes due 2021
Trading Symbol CL21A
Security Exchange Name NYSE
0.500% Notes Due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 0.500% Notes due 2026
Trading Symbol CL26
Security Exchange Name NYSE
1.375% Notes Due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Notes due 2034
Trading Symbol CL34
Security Exchange Name NYSE
0.875% Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 0.875% Notes due 2039
Trading Symbol CL39
Security Exchange Name NYSE
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net sales $ 4,344 $ 4,097
Cost of sales 1,707 1,632
Gross profit 2,637 2,465
Selling, general and administrative expenses 1,605 1,473
Other (income) expense, net 28 40
Operating profit 1,004 952
Non-service related postretirement costs 18 21
Interest (income) expense, net 29 36
Income before income taxes 957 895
Provision for income taxes 229 147
Net income including noncontrolling interests 728 748
Less: Net income attributable to noncontrolling interests 47 33
Net income attributable to Colgate-Palmolive Company $ 681 $ 715
Earnings per common share, basic (in dollars per share) $ 0.80 $ 0.83
Earnings per common share, diluted (in dollars per share) $ 0.80 $ 0.83
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Statement of Comprehensive Income [Abstract]    
Net income including noncontrolling interests $ 728 $ 748
Other comprehensive income (loss), net of tax:    
Cumulative translation adjustments (158) (355)
Retirement plans and other retiree benefit adjustments 2 16
Gains (losses) on cash flow hedges 43 18
Total Other comprehensive income (loss), net of tax (113) (321)
Total Comprehensive income including noncontrolling interests 615 427
Less: Net income attributable to noncontrolling interests 47 33
Less: Cumulative translation adjustments attributable to noncontrolling interests (3) (16)
Total Comprehensive income attributable to noncontrolling interests 44 17
Total Comprehensive income attributable to Colgate-Palmolive Company $ 571 $ 410
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 995 $ 888
Receivables (net of allowances of $89 and $89, respectively) 1,402 1,264
Inventories 1,676 1,673
Other current assets 490 513
Total current assets 4,563 4,338
Property, plant and equipment:    
Cost 8,637 8,751
Less: Accumulated depreciation (5,028) (5,035)
Property, plant and equipment, net 3,609 3,716
Goodwill 3,701 3,824
Other intangible assets, net 2,787 2,894
Deferred income taxes 201 291
Other assets 940 857
Total assets 15,801 15,920
Current Liabilities    
Notes and loans payable 254 258
Current portion of long-term debt 9 9
Accounts payable 1,306 1,393
Accrued income taxes 422 403
Other accruals 2,548 2,341
Total current liabilities 4,539 4,404
Long-term debt 7,570 7,334
Deferred income taxes 415 426
Other liabilities 2,614 2,655
Total liabilities 15,138 14,819
Shareholders’ Equity    
Common stock 1,466 1,466
Additional paid-in capital 3,011 2,969
Retained earnings 23,624 23,699
Accumulated other comprehensive income (loss) (4,455) (4,345)
Unearned compensation 0 (1)
Treasury stock, at cost (23,384) (23,045)
Total Colgate-Palmolive Company shareholders’ equity 262 743
Noncontrolling interests 401 358
Total equity 663 1,101
Total liabilities and equity $ 15,801 $ 15,920
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 89 $ 89
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Activities    
Net income including noncontrolling interests $ 728 $ 748
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:    
Depreciation and amortization 137 133
Restructuring and termination benefits, net of cash (13) (30)
Stock-based compensation expense 38 16
Deferred income taxes 6 (99)
Cash effects of changes in:    
Receivables (170) (211)
Inventories (40) 29
Accounts payable and other accruals (75) 220
Other non-current assets and liabilities (13) (38)
Net cash provided by (used in) operations 598 768
Investing Activities    
Capital expenditures (107) (82)
Purchases of marketable securities and investments (29) (42)
Proceeds from sale of marketable securities and investments 0 16
Payment for acquisitions, net of cash acquired 0 (351)
Other investing activities (6) 0
Net cash provided by (used in) investing activities (142) (459)
Financing Activities    
Short-term borrowing (repayment) less than 90 days, net 365 17
Proceeds from issuance of debt 25 0
Dividends paid (376) (373)
Purchases of treasury shares (372) (220)
Proceeds from exercise of stock options 30 297
Other financing activities (6) (29)
Net cash provided by (used in) financing activities (334) (308)
Effect of exchange rate changes on Cash and cash equivalents (15) (30)
Net increase (decrease) in Cash and cash equivalents 107 (29)
Cash and cash equivalents at beginning of the period 888 883
Cash and cash equivalents at end of the period 995 854
Supplemental Cash Flow Information    
Income taxes paid $ 227 $ 128
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Unearned Compensation
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
 [1]
Noncontrolling Interests
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses $ 3,128              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,138              
Beginning balance at Dec. 31, 2019   $ 1,466 $ 2,488 $ (2) $ (22,063) $ 22,501 $ (4,273) $ 441
Changes in Shareholders' Equity [Roll Forward]                
Net income 748         715   33
Other comprehensive income (loss), net of tax (321)           (305) (16)
Dividends [2]           (738)   (4)
Stock-based compensation expense     16          
Shares issued for stock options     133   164      
Shares issued for restricted stock units     (15)   15      
Treasury stock acquired         (220)      
Other     1 1   3    
Ending balance at Mar. 31, 2020   1,466 2,623 (1) (22,104) 22,481 (4,578) 454
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses 3,467              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,122              
Accumulated other comprehensive loss, cumulative translation losses 3,158              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs 1,178              
Beginning balance at Dec. 31, 2020 1,101 1,466 2,969 (1) (23,045) 23,699 (4,345) 358
Changes in Shareholders' Equity [Roll Forward]                
Net income 728         681   47
Other comprehensive income (loss), net of tax (113)           (110) (3)
Dividends [2]           (756)    
Stock-based compensation expense     38          
Shares issued for stock options     13   22      
Shares issued for restricted stock units     (11)   11      
Treasury stock acquired         (372)      
Other     2 1   0   (1)
Ending balance at Mar. 31, 2021 663 $ 1,466 $ 3,011 $ 0 $ (23,384) $ 23,624 $ (4,455) $ 401
Changes in Shareholders' Equity [Roll Forward]                
Accumulated other comprehensive loss, cumulative translation losses 3,313              
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs $ 1,176              
[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,313 at March 31, 2021 ($3,467 at March 31, 2020) and $3,158 at December 31, 2020 ($3,128 at December 31, 2019), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,176 at March 31, 2021 ($1,122 at March 31, 2020) and $1,178 at December 31, 2020 ($1,138 at December 31, 2019), respectively.
[2] Two dividends were declared in each of the first quarters of 2021 and 2020.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)
 3 Months Ended
Mar. 31, 2021
Dividend
$ / shares
Mar. 31, 2020
Dividend
$ / shares
Statement of Stockholders' Equity [Abstract]    
Dividends declared per common share (in dollars per share) | $ / shares [1] $ 0.89 $ 0.87
Number of dividends declared per quarter | Dividend 2 2
[1] Two dividends were declared in each of the first quarters of 2021 and 2020.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Basis of Presentation
 3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission (the “SEC”).
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Use of Estimates
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Use of Estimates Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]  
Recent Accounting Pronouncements Recent Accounting Pronouncements
In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-01, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions
 3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Acquisitions Acquisitions
Hello Products LLC (“hello”)

On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.

The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:
Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 
Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships, valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment. The Company expects that goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Related Implementation Charges
 3 Months Ended
Mar. 31, 2021
Restructuring and Related Activities [Abstract]  
Restructuring and Related Implementation Charges Restructuring and Related Implementation Charges
    
The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019 and no new restructuring projects were approved for implementation subsequent to the conclusion of the Global Growth and Efficiency Program.

During the three months ended March 31, 2021 and March 31, 2020, the Company made cash payments of $13 and $30, respectively, related to projects approved prior to the conclusion of the Global Growth and Efficiency Program.
The accrual balance at March 31, 2021 and December 31, 2020 was $19 and $31, respectively.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories
 3 Months Ended
Mar. 31, 2021
Inventory, Net, Items Net of Reserve Alternative [Abstract]  
Inventories Inventories
Inventories by major class are as follows:
March 31,
2021		December 31,
2020
Raw materials and supplies$463 $454 
Work-in-process48 45 
Finished goods1,264 1,256 
       Total Inventories, net$1,775 $1,755 
            Non-current inventory, net$(99)$(82)
              Current Inventories, net$1,676 $1,673 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
For the three months ended March 31, 2021 and 2020, earnings per share were as follows:
 Three Months Ended
 March 31, 2021March 31, 2020
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share		Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share
Basic EPS$681 848.6 $0.80 $715 856.9 $0.83 
Stock options and
restricted stock units
2.8   1.5  
Diluted EPS$681 851.4 $0.80 $715 858.4 $0.83 
For the three months ended March 31, 2021 and 2020, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,721,084 and 20,965,110, respectively.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Other Comprehensive Income (Loss)
 3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Other Comprehensive Income (Loss) Other Comprehensive Income (Loss)
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2021 and 2020 were as follows:
 20212020
PretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(99)$(155)$(320)$(339)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period(19)(14)2 1 
Amortization of net actuarial loss, transition and prior service costs (1)
22 16 17 15 
Retirement plans and other retiree benefits adjustments3 2 19 16 
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges53 41 25 20 
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
3 2 (3)(2)
Gains (losses) on cash flow hedges56 43 22 18 
Total Other comprehensive income (loss)$(40)$(110)$(279)$(305)
(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Retirement Plans and Other Retiree Benefits
 3 Months Ended
Mar. 31, 2021
Retirement Benefits [Abstract]  
Retirement Plans and Other Retiree Benefits Retirement Plans and Other Retiree Benefits
Components of Net periodic benefit cost for the three months ended March 31, 2021 and 2020 were as follows:
Three Months Ended March 31, 2021
 Pension BenefitsOther Retiree Benefits
 United StatesInternational  
 202120202021202020212020
Service cost$— $— $4 $4 $6 $6 
Interest cost15 19 5 5 9 11 
Expected return on plan assets(27)(27)(6)(4)— — 
Amortization of actuarial loss (gain)13 11 3 1 6 5 
Net periodic benefit cost
$1 $3 $6 $6 $21 $22 

For the three months ended March 31, 2021 and 2020, the Company made no voluntary contributions to its U.S. postretirement plans.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
 3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The provision for income taxes for the quarter ended March 31, 2020 includes $71 of income tax benefits recorded on a discrete period basis of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Acts (the “TCJA”).

As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes would be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, in the first quarter of 2020, reversed $45 of previously recorded foreign withholding taxes.
Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, in the first quarter of 2020, reversed the previously recorded valuation allowance of $26.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Contingencies
 3 Months Ended
Mar. 31, 2021
Loss Contingency [Abstract]  
Contingencies Contingencies
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $400 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.
Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $103. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.

In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $45, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.
Competition Matter

Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of March 31, 2021 of such competition law matters pending against the Company during the three months ended March 31, 2021 is set forth below.

▪In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2021, there were 147 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 137 cases as of December 31, 2020. During the three months ended March 31, 2021, 14 new cases were filed and three cases were resolved by voluntary dismissal. In addition, during the three months ended March 31, 2021, the Company won an appeal in one case that, in 2019, resulted in a jury verdict in favor of the Company and, since all of the plaintiff’s appeals have been exhausted, the case is now closed. There were no settlements of pending cases in the three months ended March 31, 2021.

A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes a portion of such costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of one case where the Company received an adverse jury verdict in the second quarter of 2019 that the Company has appealed, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter
In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
Three Months Ended
 March 31,
 20212020
Net sales  
Oral, Personal and Home Care  
North America$923 $929 
Latin America907 889 
Europe717 675 
Asia Pacific739 633 
Africa/Eurasia272 252 
Total Oral, Personal and Home Care3,558 3,378 
Pet Nutrition786 719 
Total Net sales$4,344 $4,097 
Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Three Months Ended
 March 31,
 20212020
Net sales
Oral Care45 %44 %
Personal Care19 %20 %
Home Care18 %18 %
Pet Nutrition18 %18 %
Total Net sales100 %100 %
Operating profit by segment was as follows:
Three Months Ended
 March 31,
 20212020
Operating profit  
Oral, Personal and Home Care  
North America$202 $258 
Latin America272 248 
Europe180 154 
Asia Pacific224 161 
Africa/Eurasia54 56 
Total Oral, Personal and Home Care932 877 
Pet Nutrition215 203 
Corporate(143)(128)
Total Operating profit$1,004 $952 
For the three months ended March 31, 2020, Corporate Operating profit (loss) included acquisition-related costs of $6.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Financial Instruments Fair Value Measurements and Financial Instruments
The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2021 and December 31, 2020:
 AssetsLiabilities
  
Account		Fair ValueAccountFair Value
Designated derivative instrumentsMarch 31, 2021December 31, 2020 March 31, 2021December 31, 2020
Interest rate swap contractsOther assets$11 $14 Other liabilities$— $— 
Forward-starting interest rate swapsOther assets51 5 Other liabilities— — 
Foreign currency contractsOther current assets13 7 Other accruals55 93 
Commodity contractsOther current assets2 3 Other accruals— — 
Total designated$77 $29  $55 $93 
Other financial instruments     
Marketable securitiesOther current assets$62 $37    
Total other financial instruments$62 $37    
The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of March 31, 2021 and December 31, 2020. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2021 and December 31, 2020, was $8,097 and $8,175, respectively, and the related carrying value was $7,579 and $7,343, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:
March 31, 2021December 31, 2020
Long-term debt:  
Carrying amount of hedged item$411 $413 
Cumulative hedging adjustment included in the carrying amount11 14 
The following tables present the notional values as of:
 March 31, 2021
 Foreign Currency ContractsForeign Currency DebtInterest Rate Swaps Forward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $527 $— $400 $— $— $927 
Cash Flow Hedges 825 — — 600 19 1,444 
Net Investment Hedges604 4,164 — — — 4,768 
 December 31, 2020
 Foreign Currency ContractsForeign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $— $400 $— $— $989 
Cash Flow Hedges 854 — — 300 17 1,171 
Net Investment Hedges528 4,523 — — — 5,051 
The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
Three Months Ended March 31,
 20212020
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Interest rate swaps designated as fair value hedges:
Derivative instrument$— $— $2 $— $— $(12)
Hedged items— — (2)— — 12 
Foreign currency contracts designated as fair value hedges:
Derivative instrument— — — — 24 — 
Hedged items— — — — (24)— 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI(6)— — 2 — — 
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI3 — — 1 — — 
Total gain (loss) on hedges recognized in income$(3)$— $— $3 $— $— 


The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
20212020
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$6 $25 
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI46 — 
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI1 — 
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments23 25 
Gain (loss) on hedged items(23)(25)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments211 65 
Gain (loss) on hedged items(211)(65)
Total unrealized gain (loss) on hedges recognized in OCI$53 $25 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Use of Estimates (Policies)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Use of Estimates Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
Recent Accounting Pronouncements Recent Accounting Pronouncements
In January 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2021-01, “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This guidance was effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company is currently evaluating the impact of the new guidance and does not expect this standard to have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions (Tables)
 3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:
Receivables $11 
Inventories 13 
Other assets and liabilities, net (4)
Other intangible assets 160 
Goodwill171 
Fair value of net assets acquired$351 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2021
Inventory, Net, Items Net of Reserve Alternative [Abstract]  
Inventories by Major Class
Inventories by major class are as follows:
March 31,
2021		December 31,
2020
Raw materials and supplies$463 $454 
Work-in-process48 45 
Finished goods1,264 1,256 
       Total Inventories, net$1,775 $1,755 
            Non-current inventory, net$(99)$(82)
              Current Inventories, net$1,676 $1,673 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
For the three months ended March 31, 2021 and 2020, earnings per share were as follows:
 Three Months Ended
 March 31, 2021March 31, 2020
 Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share		Net income attributable to Colgate-Palmolive CompanyShares
(millions)		Per
Share
Basic EPS$681 848.6 $0.80 $715 856.9 $0.83 
Stock options and
restricted stock units
2.8   1.5  
Diluted EPS$681 851.4 $0.80 $715 858.4 $0.83 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Comprehensive Income (Loss)
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2021 and 2020 were as follows:
 20212020
PretaxNet of TaxPretaxNet of Tax
Cumulative translation adjustments$(99)$(155)$(320)$(339)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period(19)(14)2 1 
Amortization of net actuarial loss, transition and prior service costs (1)
22 16 17 15 
Retirement plans and other retiree benefits adjustments3 2 19 16 
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges53 41 25 20 
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
3 2 (3)(2)
Gains (losses) on cash flow hedges56 43 22 18 
Total Other comprehensive income (loss)$(40)$(110)$(279)$(305)
(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Retirement Plans and Other Retiree Benefits (Tables)
 3 Months Ended
Mar. 31, 2021
Retirement Benefits [Abstract]  
Components Of Net Periodic Benefit Cost
Components of Net periodic benefit cost for the three months ended March 31, 2021 and 2020 were as follows:
Three Months Ended March 31, 2021
 Pension BenefitsOther Retiree Benefits
 United StatesInternational  
 202120202021202020212020
Service cost$— $— $4 $4 $6 $6 
Interest cost15 19 5 5 9 11 
Expected return on plan assets(27)(27)(6)(4)— — 
Amortization of actuarial loss (gain)13 11 3 1 6 5 
Net periodic benefit cost
$1 $3 $6 $6 $21 $22 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Net Sales and Operating Profit by Segment
Net sales by segment were as follows:
Three Months Ended
 March 31,
 20212020
Net sales  
Oral, Personal and Home Care  
North America$923 $929 
Latin America907 889 
Europe717 675 
Asia Pacific739 633 
Africa/Eurasia272 252 
Total Oral, Personal and Home Care3,558 3,378 
Pet Nutrition786 719 
Total Net sales$4,344 $4,097 
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Three Months Ended
 March 31,
 20212020
Net sales
Oral Care45 %44 %
Personal Care19 %20 %
Home Care18 %18 %
Pet Nutrition18 %18 %
Total Net sales100 %100 %
Operating profit by segment was as follows:
Three Months Ended
 March 31,
 20212020
Operating profit  
Oral, Personal and Home Care  
North America$202 $258 
Latin America272 248 
Europe180 154 
Asia Pacific224 161 
Africa/Eurasia54 56 
Total Oral, Personal and Home Care932 877 
Pet Nutrition215 203 
Corporate(143)(128)
Total Operating profit$1,004 $952 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of derivative instruments
The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2021 and December 31, 2020:
 AssetsLiabilities
  
Account		Fair ValueAccountFair Value
Designated derivative instrumentsMarch 31, 2021December 31, 2020 March 31, 2021December 31, 2020
Interest rate swap contractsOther assets$11 $14 Other liabilities$— $— 
Forward-starting interest rate swapsOther assets51 5 Other liabilities— — 
Foreign currency contractsOther current assets13 7 Other accruals55 93 
Commodity contractsOther current assets2 3 Other accruals— — 
Total designated$77 $29  $55 $93 
Other financial instruments     
Marketable securitiesOther current assets$62 $37    
Total other financial instruments$62 $37    
Schedule of hedged item and cumulative adjustment to carrying amount
The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:
March 31, 2021December 31, 2020
Long-term debt:  
Carrying amount of hedged item$411 $413 
Cumulative hedging adjustment included in the carrying amount11 14 
Schedule of notional values
The following tables present the notional values as of:
 March 31, 2021
 Foreign Currency ContractsForeign Currency DebtInterest Rate Swaps Forward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $527 $— $400 $— $— $927 
Cash Flow Hedges 825 — — 600 19 1,444 
Net Investment Hedges604 4,164 — — — 4,768 
 December 31, 2020
 Foreign Currency ContractsForeign Currency DebtInterest Rate SwapsForward-Starting Interest Rate SwapsCommodity Contracts 
Total
Fair Value Hedges $589 $— $400 $— $— $989 
Cash Flow Hedges 854 — — 300 17 1,171 
Net Investment Hedges528 4,523 — — — 5,051 
Schedule of gains (losses) recognized in Statements of Income
The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
Three Months Ended March 31,
 20212020
Cost of sales Selling, general and administrative expensesInterest (income) expense, netCost of salesSelling, general and administrative expensesInterest (income) expense, net
Interest rate swaps designated as fair value hedges:
Derivative instrument$— $— $2 $— $— $(12)
Hedged items— — (2)— — 12 
Foreign currency contracts designated as fair value hedges:
Derivative instrument— — — — 24 — 
Hedged items— — — — (24)— 
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI(6)— — 2 — — 
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI3 — — 1 — — 
Total gain (loss) on hedges recognized in income$(3)$— $— $3 $— $— 
Schedule of gains (losses) included in Other Comprehensive Income
The following table presents the location and amount of unrealized gains (losses) included in OCI:
 
Three Months Ended
March 31,
20212020
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI$6 $25 
Forward-starting interest rate swaps designated as cash flow hedges:
Gain (loss) recognized in OCI46 — 
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI1 — 
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments23 25 
Gain (loss) on hedged items(23)(25)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments211 65 
Gain (loss) on hedged items(211)(65)
Total unrealized gain (loss) on hedges recognized in OCI$53 $25 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions - Narrative (Details) - USD ($)
$ in Millions
Jan. 31, 2020
Mar. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Goodwill   $ 3,701 $ 3,824
Hello Product LLC      
Business Acquisition [Line Items]      
Payments to acquire business $ 351    
Purchase price consideration 351    
Other intangible assets 160    
Goodwill 171    
Hello Product LLC | North America      
Business Acquisition [Line Items]      
Goodwill 171    
Hello Product LLC | Trademarks      
Business Acquisition [Line Items]      
Other intangible assets $ 115    
Useful life 25 years    
Hello Product LLC | Customer Relationships      
Business Acquisition [Line Items]      
Other intangible assets $ 45    
Useful life 17 years    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Jan. 31, 2020
Business Acquisition [Line Items]      
Goodwill $ 3,701 $ 3,824  
Hello Product LLC      
Business Acquisition [Line Items]      
Receivables     $ 11
Inventories     13
Other assets and liabilities, net     (4)
Other intangible assets     160
Goodwill     171
Fair value of net assets acquired     $ 351
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Related Implementation Charges - Narrative (Details) - Global Growth and Efficiency Program - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Payments for restructuring $ 13 $ 30  
Restructuring reserve $ 19   $ 31
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Inventory, Net, Items Net of Reserve Alternative [Abstract]    
Raw materials and supplies $ 463 $ 454
Work-in-process 48 45
Finished goods 1,264 1,256
Total Inventories, net 1,775 1,755
Non-current inventory, net (99) (82)
Current Inventories, net $ 1,676 $ 1,673
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net income attributable to Colgate-Palmolive Company    
Basic EPS $ 681 $ 715
Diluted EPS $ 681 $ 715
Shares (millions)    
Basic EPS (in shares) 848,600,000 856,900,000
Stock options and restricted stock units (in shares) 2,800,000 1,500,000
Diluted EPS (in shares) 851,400,000 858,400,000
Per Share    
Basic EPS (in dollars per share) $ 0.80 $ 0.83
Diluted EPS (in dollars per share) $ 0.80 $ 0.83
Antidilutive securities excluded from computation of earnings per share (in shares) 2,721,084 20,965,110
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Total Other comprehensive income (loss), net of tax $ (113) $ (321)
Cumulative translation adjustments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax (99) (320)
Other comprehensive income (loss), pretax (99) (320)
Total Other comprehensive income (loss), net of tax (155) (339)
Retirement plans and other retiree benefits adjustments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax 3 19
Other comprehensive income (loss), before reclassifications, pretax (19) 2
Reclassification from AOCI, pretax 22 17
Other comprehensive income (loss), pretax 3 19
Other comprehensive income (loss), before reclassifications, net of tax (14) 1
Reclassification from AOCI, net of tax 16 15
Total Other comprehensive income (loss), net of tax 2 16
Gains (losses) on cash flow hedges    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax 56 22
Other comprehensive income (loss), before reclassifications, pretax 53 25
Reclassification from AOCI, pretax 3 (3)
Other comprehensive income (loss), pretax 56 22
Other comprehensive income (loss), before reclassifications, net of tax 41 20
Reclassification from AOCI, net of tax 2 (2)
Total Other comprehensive income (loss), net of tax 43 18
Total Other comprehensive income (loss)    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax (40) (279)
Other comprehensive income (loss), pretax (40) (279)
Total Other comprehensive income (loss), net of tax [1] $ (110) $ (305)
[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,313 at March 31, 2021 ($3,467 at March 31, 2020) and $3,158 at December 31, 2020 ($3,128 at December 31, 2019), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,176 at March 31, 2021 ($1,122 at March 31, 2020) and $1,178 at December 31, 2020 ($1,138 at December 31, 2019), respectively.
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Retirement Plans and Other Retiree Benefits (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Other Retiree Benefits    
Components of net periodic benefit cost    
Service cost $ 6,000,000 $ 6,000,000
Interest cost 9,000,000 11,000,000
Expected return on plan assets 0 0
Amortization of actuarial loss (gain) 6,000,000 5,000,000
Net periodic benefit cost 21,000,000 22,000,000
United States | Pension Benefits    
Components of net periodic benefit cost    
Service cost 0 0
Interest cost 15,000,000 19,000,000
Expected return on plan assets (27,000,000) (27,000,000)
Amortization of actuarial loss (gain) 13,000,000 11,000,000
Net periodic benefit cost 1,000,000 3,000,000
Voluntary benefit plan contribution 0 0
International | Pension Benefits    
Components of net periodic benefit cost    
Service cost 4,000,000 4,000,000
Interest cost 5,000,000 5,000,000
Expected return on plan assets (6,000,000) (4,000,000)
Amortization of actuarial loss (gain) 3,000,000 1,000,000
Net periodic benefit cost $ 6,000,000 $ 6,000,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Tax Disclosure [Abstract]    
Provisional income tax benefit $ 71,000,000  
Foreign withholding income tax 45,000,000 $ 45,000,000
Valuation allowance against deferred tax asset $ 26,000,000 26,000,000
Withholding tax due   $ 0
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Contingencies (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2021
USD ($)
country_and_territory
case
Dec. 31, 2019
case
Dec. 31, 2020
case
Apr. 30, 2019
USD ($)
Jul. 31, 2017
USD ($)
Dec. 31, 2005
USD ($)
Loss Contingencies [Line Items]            
Number of countries in which entity operates | country_and_territory 200          
Brazilian internal revenue authority, matter 1 | $ $ 103.0          
Loss contingency, number of cases on appeal 5          
Brazilian internal revenue authority, matter 2 | $           $ 45.0
Fine imposed by Greek competition authority | $       $ 10.5 $ 11.0  
Loss contingency, pending claims, number (in cases) 147   137      
Loss contingency, new claims filed, number (in cases) 14          
Loss contingency, claims dismissed or settled, number (in cases) 3          
Loss contingency, claims previously dismissed, number affirmed on appeal 1          
Loss contingency, number of cases resulting in adverse jury verdict   1        
Minimum            
Loss Contingencies [Line Items]            
Range of reasonably possible losses | $ $ 0.0          
Maximum            
Loss Contingencies [Line Items]            
Range of reasonably possible losses | $ $ 400.0          
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2021
segment
Mar. 31, 2020
USD ($)
Segment Reporting Information [Line Items]    
Number of product segments (in segments) 2  
Number of reportable segments (in segments) 5  
Number of operating segments (in segments) 5  
Corporate | Included in Operating profit (loss)    
Segment Reporting Information [Line Items]    
Acquisition related costs | $   $ 6
Net Sales    
Segment Reporting Information [Line Items]    
Percentage of consolidated Net sales represented by sales outside US 70.00%  
Percentage of consolidated Net sales coming from emerging markets 45.00%  
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Total Net sales $ 4,344 $ 4,097
Total operating profit $ 1,004 $ 952
Product Concentration Risk | Net Sales    
Segment Reporting Information [Line Items]    
Percent of net sales 100.00% 100.00%
Product Concentration Risk | Net Sales | Oral Care    
Segment Reporting Information [Line Items]    
Percent of net sales 45.00% 44.00%
Product Concentration Risk | Net Sales | Personal Care    
Segment Reporting Information [Line Items]    
Percent of net sales 19.00% 20.00%
Product Concentration Risk | Net Sales | Home Care    
Segment Reporting Information [Line Items]    
Percent of net sales 18.00% 18.00%
Product Concentration Risk | Net Sales | Pet Nutrition    
Segment Reporting Information [Line Items]    
Percent of net sales 18.00% 18.00%
Operating Segments | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales $ 3,558 $ 3,378
Total operating profit 932 877
Operating Segments | Pet Nutrition    
Segment Reporting Information [Line Items]    
Total Net sales 786 719
Total operating profit 215 203
Operating Segments | North America | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales 923 929
Total operating profit 202 258
Operating Segments | Latin America | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales 907 889
Total operating profit 272 248
Operating Segments | Europe | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales 717 675
Total operating profit 180 154
Operating Segments | Asia Pacific | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales 739 633
Total operating profit 224 161
Operating Segments | Africa/Eurasia | Oral, Personal and Home Care    
Segment Reporting Information [Line Items]    
Total Net sales 272 252
Total operating profit 54 56
Corporate    
Segment Reporting Information [Line Items]    
Total operating profit $ (143) $ (128)
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Designated derivative instruments    
Derivative assets $ 77 $ 29
Derivative liabilities 55 93
Other financial instruments    
Total other financial instruments 62 37
Other assets | Interest rate swap contracts    
Designated derivative instruments    
Derivative assets 11 14
Other assets | Forward-starting interest rate swaps    
Designated derivative instruments    
Derivative assets 51 5
Other current assets    
Other financial instruments    
Marketable securities 62 37
Other current assets | Foreign currency contracts    
Designated derivative instruments    
Derivative assets 13 7
Other current assets | Commodity contracts    
Designated derivative instruments    
Derivative assets 2 3
Other liabilities | Interest rate swap contracts    
Designated derivative instruments    
Derivative liabilities 0 0
Other liabilities | Forward-starting interest rate swaps    
Designated derivative instruments    
Derivative liabilities 0 0
Other accruals | Foreign currency contracts    
Designated derivative instruments    
Derivative liabilities 55 93
Other accruals | Commodity contracts    
Designated derivative instruments    
Derivative liabilities $ 0 $ 0
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Carrying Value    
Debt Instrument [Line Items]    
Carrying value of long-term debt $ 7,579 $ 7,343
Fair Value, Inputs, Level 2    
Debt Instrument [Line Items]    
Estimated fair value of long-term debt $ 8,097 $ 8,175
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - Long-term Debt - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Carrying amount of hedged item $ 411 $ 413
Cumulative hedging adjustment included in the carrying amount $ 11 $ 14
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values $ 927 $ 989
Fair Value Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 527 589
Fair Value Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Fair Value Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 400 400
Fair Value Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Fair Value Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 1,444 1,171
Cash Flow Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 825 854
Cash Flow Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Cash Flow Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 600 300
Cash Flow Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 19 17
Net Investment Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 4,768 5,051
Net Investment Hedges | Foreign Currency Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 604 528
Net Investment Hedges | Foreign Currency Debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 4,164 4,523
Net Investment Hedges | Interest Rate Swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Net Investment Hedges | Forward-starting interest rate swaps    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values 0 0
Net Investment Hedges | Commodity Contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional values $ 0 $ 0
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cost of sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income $ (3) $ 3
Cost of sales | Interest Rate Swaps | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Cost of sales | Foreign Currency Contracts | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Cost of sales | Foreign Currency Contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI (6) 2
Cost of sales | Commodity contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 3 1
Selling, general and administrative expenses    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Selling, general and administrative expenses | Interest Rate Swaps | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Selling, general and administrative expenses | Foreign Currency Contracts | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 24
Gain (loss) on hedged items 0 (24)
Selling, general and administrative expenses | Foreign Currency Contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 0 0
Selling, general and administrative expenses | Commodity contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 0 0
Interest (income) expense, net    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain (loss) on hedges recognized in income 0 0
Interest (income) expense, net | Interest Rate Swaps | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 2 (12)
Gain (loss) on hedged items (2) 12
Interest (income) expense, net | Foreign Currency Contracts | Fair Value Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) on derivative instrument 0 0
Gain (loss) on hedged items 0 0
Interest (income) expense, net | Foreign Currency Contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI 0 0
Interest (income) expense, net | Commodity contracts | Cash Flow Hedges    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount reclassified from OCI $ 0 $ 0
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI $ 53 $ 25
Foreign Currency Contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 6 25
Net investment hedges [Abstract]    
Gain (loss) on instruments 23 25
Gain (loss) on hedged items (23) (25)
Forward-starting interest rate swaps    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 46 0
Commodity Contracts    
Cash flow hedges [Abstract]    
Gain (loss) recognized in OCI 1 0
Foreign Currency Debt    
Net investment hedges [Abstract]    
Gain (loss) on instruments 211 65
Gain (loss) on hedged items $ (211) $ (65)
EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 58 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 206 285 1 true 59 0 false 8 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.colgate.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME CONDENSED CONSOLIDATED STATEMENTS OF INCOME Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 7 false false R8.htm 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Sheet http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Statements 8 false false R9.htm 2101101 - Disclosure - Basis of Presentation Sheet http://www.colgate.com/role/BasisofPresentation Basis of Presentation Notes 9 false false R10.htm 2102102 - Disclosure - Use of Estimates Sheet http://www.colgate.com/role/UseofEstimates Use of Estimates Notes 10 false false R11.htm 2104103 - Disclosure - Recent Accounting Pronouncements Sheet http://www.colgate.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 11 false false R12.htm 2105104 - Disclosure - Acquisitions Sheet http://www.colgate.com/role/Acquisitions Acquisitions Notes 12 false false R13.htm 2109105 - Disclosure - Restructuring and Related Implementation Charges Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationCharges Restructuring and Related Implementation Charges Notes 13 false false R14.htm 2111106 - Disclosure - Inventories Sheet http://www.colgate.com/role/Inventories Inventories Notes 14 false false R15.htm 2114107 - Disclosure - Earnings Per Share Sheet http://www.colgate.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2117108 - Disclosure - Other Comprehensive Income (Loss) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLoss Other Comprehensive Income (Loss) Notes 16 false false R17.htm 2120109 - Disclosure - Retirement Plans and Other Retiree Benefits Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits Retirement Plans and Other Retiree Benefits Notes 17 false false R18.htm 2123110 - Disclosure - Income Taxes Sheet http://www.colgate.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2125111 - Disclosure - Contingencies Sheet http://www.colgate.com/role/Contingencies Contingencies Notes 19 false false R20.htm 2127112 - Disclosure - Segment Information Sheet http://www.colgate.com/role/SegmentInformation Segment Information Notes 20 false false R21.htm 2131113 - Disclosure - Fair Value Measurements and Financial Instruments Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments Fair Value Measurements and Financial Instruments Notes 21 false false R22.htm 2203201 - Disclosure - Use of Estimates (Policies) Sheet http://www.colgate.com/role/UseofEstimatesPolicies Use of Estimates (Policies) Policies http://www.colgate.com/role/RecentAccountingPronouncements 22 false false R23.htm 2306301 - Disclosure - Acquisitions (Tables) Sheet http://www.colgate.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.colgate.com/role/Acquisitions 23 false false R24.htm 2312302 - Disclosure - Inventories (Tables) Sheet http://www.colgate.com/role/InventoriesTables Inventories (Tables) Tables http://www.colgate.com/role/Inventories 24 false false R25.htm 2315303 - Disclosure - Earnings Per Share (Tables) Sheet http://www.colgate.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.colgate.com/role/EarningsPerShare 25 false false R26.htm 2318304 - Disclosure - Other Comprehensive Income (Loss) (Tables) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLossTables Other Comprehensive Income (Loss) (Tables) Tables http://www.colgate.com/role/OtherComprehensiveIncomeLoss 26 false false R27.htm 2321305 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables Retirement Plans and Other Retiree Benefits (Tables) Tables http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits 27 false false R28.htm 2328306 - Disclosure - Segment Information (Tables) Sheet http://www.colgate.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.colgate.com/role/SegmentInformation 28 false false R29.htm 2332307 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables Fair Value Measurements and Financial Instruments (Tables) Tables http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments 29 false false R30.htm 2407401 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.colgate.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 30 false false R31.htm 2408402 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Sheet http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) Details 31 false false R32.htm 2410403 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details) Sheet http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails Restructuring and Related Implementation Charges - Narrative (Details) Details http://www.colgate.com/role/RestructuringandRelatedImplementationCharges 32 false false R33.htm 2413404 - Disclosure - Inventories (Details) Sheet http://www.colgate.com/role/InventoriesDetails Inventories (Details) Details http://www.colgate.com/role/InventoriesTables 33 false false R34.htm 2416405 - Disclosure - Earnings Per Share (Details) Sheet http://www.colgate.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.colgate.com/role/EarningsPerShareTables 34 false false R35.htm 2419406 - Disclosure - Other Comprehensive Income (Loss) (Details) Sheet http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails Other Comprehensive Income (Loss) (Details) Details http://www.colgate.com/role/OtherComprehensiveIncomeLossTables 35 false false R36.htm 2422407 - Disclosure - Retirement Plans and Other Retiree Benefits (Details) Sheet http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails Retirement Plans and Other Retiree Benefits (Details) Details http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables 36 false false R37.htm 2424408 - Disclosure - Income Taxes (Details) Sheet http://www.colgate.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.colgate.com/role/IncomeTaxes 37 false false R38.htm 2426409 - Disclosure - Contingencies (Details) Sheet http://www.colgate.com/role/ContingenciesDetails Contingencies (Details) Details http://www.colgate.com/role/Contingencies 38 false false R39.htm 2429410 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.colgate.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 39 false false R40.htm 2430411 - Disclosure - Segment Information - Schedule of Segment Information (Details) Sheet http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails Segment Information - Schedule of Segment Information (Details) Details 40 false false R41.htm 2433412 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) Details 41 false false R42.htm 2434413 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails Fair Value Measurements and Financial Instruments - Narrative (Details) Details http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables 42 false false R43.htm 2435414 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) Details 43 false false R44.htm 2436415 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) Details 44 false false R45.htm 2437416 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) Details 45 false false R46.htm 2438417 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Sheet http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) Details 46 false false All Reports Book All Reports cl-20210331.htm cl-20210331.xsd cl-20210331_cal.xml cl-20210331_def.xml cl-20210331_lab.xml cl-20210331_pre.xml exhibit31a_033121xq12021.htm exhibit31b_033121xq12021.htm exhibit32_033121xq12021.htm http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cl-20210331.htm": { "axisCustom": 0, "axisStandard": 21, "contextCount": 206, "dts": { "calculationLink": { "local": [ "cl-20210331_cal.xml" ] }, "definitionLink": { "local": [ "cl-20210331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "cl-20210331.htm" ] }, "labelLink": { "local": [ "cl-20210331_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "cl-20210331_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "cl-20210331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 384, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 5 }, "keyCustom": 20, "keyStandard": 265, "memberCustom": 14, "memberStandard": 43, "nsprefix": "cl", "nsuri": "http://www.colgate.com/20210331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.colgate.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "us-gaap:UseOfEstimates", "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - Use of Estimates", "role": "http://www.colgate.com/role/UseofEstimates", "shortName": "Use of Estimates", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:UseOfEstimates", "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104103 - Disclosure - Recent Accounting Pronouncements", "role": "http://www.colgate.com/role/RecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105104 - Disclosure - Acquisitions", "role": "http://www.colgate.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109105 - Disclosure - Restructuring and Related Implementation Charges", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationCharges", "shortName": "Restructuring and Related Implementation Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111106 - Disclosure - Inventories", "role": "http://www.colgate.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114107 - Disclosure - Earnings Per Share", "role": "http://www.colgate.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117108 - Disclosure - Other Comprehensive Income (Loss)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLoss", "shortName": "Other Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120109 - Disclosure - Retirement Plans and Other Retiree Benefits", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits", "shortName": "Retirement Plans and Other Retiree Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123110 - Disclosure - Income Taxes", "role": "http://www.colgate.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125111 - Disclosure - Contingencies", "role": "http://www.colgate.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127112 - Disclosure - Segment Information", "role": "http://www.colgate.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2131113 - Disclosure - Fair Value Measurements and Financial Instruments", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments", "shortName": "Fair Value Measurements and Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2203201 - Disclosure - Use of Estimates (Policies)", "role": "http://www.colgate.com/role/UseofEstimatesPolicies", "shortName": "Use of Estimates (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Acquisitions (Tables)", "role": "http://www.colgate.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312302 - Disclosure - Inventories (Tables)", "role": "http://www.colgate.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315303 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.colgate.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318304 - Disclosure - Other Comprehensive Income (Loss) (Tables)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLossTables", "shortName": "Other Comprehensive Income (Loss) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321305 - Disclosure - Retirement Plans and Other Retiree Benefits (Tables)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables", "shortName": "Retirement Plans and Other Retiree Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328306 - Disclosure - Segment Information (Tables)", "role": "http://www.colgate.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2332307 - Disclosure - Fair Value Measurements and Financial Instruments (Tables)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables", "shortName": "Fair Value Measurements and Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407401 - Disclosure - Acquisitions - Narrative (Details)", "role": "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i217b0d5296d44b8cb7f0364270df6cae_D20200131-20200131", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisitions - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "id3a55ae746ed462caec6f1bc38fcc4e8_I20200131", "decimals": "-6", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic8eefd3045a344b780dfe1019ced710e_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForRestructuring", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410403 - Disclosure - Restructuring and Related Implementation Charges - Narrative (Details)", "role": "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "shortName": "Restructuring and Related Implementation Charges - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic8eefd3045a344b780dfe1019ced710e_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForRestructuring", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413404 - Disclosure - Inventories (Details)", "role": "http://www.colgate.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416405 - Disclosure - Earnings Per Share (Details)", "role": "http://www.colgate.com/role/EarningsPerShareDetails", "shortName": "Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419406 - Disclosure - Other Comprehensive Income (Loss) (Details)", "role": "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails", "shortName": "Other Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i6892fb158e354fe8a7a76669c00447f4_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i99d662f8bf6f4523a2f45e24b581ae34_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422407 - Disclosure - Retirement Plans and Other Retiree Benefits (Details)", "role": "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails", "shortName": "Retirement Plans and Other Retiree Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i99d662f8bf6f4523a2f45e24b581ae34_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:DiscreteIncomeTaxProvisionBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424408 - Disclosure - Income Taxes (Details)", "role": "http://www.colgate.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cl:DiscreteIncomeTaxProvisionBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426409 - Disclosure - Contingencies (Details)", "role": "http://www.colgate.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "country_and_territory", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfProductSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429410 - Disclosure - Segment Information - Narrative (Details)", "role": "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "cl:NumberOfProductSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430411 - Disclosure - Segment Information - Schedule of Segment Information (Details)", "role": "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails", "shortName": "Segment Information - Schedule of Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i98677dd40e58494eb92f2685e0c456e1_D20210101-20210331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433412 - Disclosure - Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "shortName": "Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i56bbfb4ebcfe4982bc21a87646915586_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434413 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value Measurements and Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i56bbfb4ebcfe4982bc21a87646915586_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i5753f4d335c1477d85d9c179cecec20d_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435414 - Disclosure - Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "shortName": "Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i5753f4d335c1477d85d9c179cecec20d_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HedgedLiabilityFairValueHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i7089dc2fe5ed4eaa89b6cfdf52d83d50_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436415 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i7089dc2fe5ed4eaa89b6cfdf52d83d50_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i47d897371d784fc68e8bd9c53f4e9708_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437416 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i47d897371d784fc68e8bd9c53f4e9708_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438417 - Disclosure - Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "role": "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "shortName": "Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cl:ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i91969b0b5c5042cca329726f65b80ac3_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i502cc3f19dac454a8f3302be39be11c1_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "i502cc3f19dac454a8f3302be39be11c1_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "role": "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Basis of Presentation", "role": "http://www.colgate.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cl-20210331.htm", "contextRef": "ic877a53af096441c9544a3c9fa4519fb_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 59, "tag": { "cl_A0.000Notesdue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.000% Notes due 2021 [Member]", "label": "0.000% Notes due 2021 [Member]", "terseLabel": "0.000% Notes due 2021" } } }, "localname": "A0.000Notesdue2021Member", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A0.500NotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.500% Notes Due 2026 [Member]", "label": "0.500% Notes Due 2026 [Member]", "terseLabel": "0.500% Notes Due 2026" } } }, "localname": "A0.500NotesDue2026Member", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A0.875Notesdue2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.875% Notes due 2039 [Member]", "label": "0.875% Notes due 2039 [Member]", "terseLabel": "0.875% Notes due 2039" } } }, "localname": "A0.875Notesdue2039Member", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_A1.375NotesDue2034Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.375% Notes Due 2034 [Member]", "label": "1.375% Notes Due 2034 [Member]", "terseLabel": "1.375% Notes Due 2034" } } }, "localname": "A1.375NotesDue2034Member", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "cl_AfricaEurasiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A specified group of foreign regions about which segment information is provided by the entity.", "label": "Africa Eurasia [Member]", "terseLabel": "Africa/Eurasia" } } }, "localname": "AfricaEurasiaMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets And Liabilities, Other, Net", "negatedTerseLabel": "Other assets and liabilities, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAndLiabilitiesOtherNet", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "cl_DesignatedDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated derivative instruments [Abstract]", "label": "Designated derivative instruments [Abstract]", "terseLabel": "Designated derivative instruments" } } }, "localname": "DesignatedDerivativeInstrumentsAbstract", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "cl_DiscreteIncomeTaxProvisionBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discrete Income Tax Provision (Benefit)", "label": "Discrete Income Tax Provision (Benefit)", "negatedLabel": "Provisional income tax benefit" } } }, "localname": "DiscreteIncomeTaxProvisionBenefit", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "cl_FineImposedByGreekCompetitionAuthority": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fine Imposed by Greek Competition Authority", "label": "Fine Imposed By Greek Competition Authority", "terseLabel": "Fine imposed by Greek competition authority" } } }, "localname": "FineImposedByGreekCompetitionAuthority", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_ForeignWithholdingIncomeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign Withholding Income Tax", "label": "Foreign Withholding Income Tax", "negatedTerseLabel": "Foreign withholding income tax" } } }, "localname": "ForeignWithholdingIncomeTax", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "cl_GlobalGrowthandEfficiencyProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Growth and Efficiency Program [Member]", "label": "Global Growth and Efficiency Program [Member]", "terseLabel": "Global Growth and Efficiency Program" } } }, "localname": "GlobalGrowthandEfficiencyProgramMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "cl_HelloProductLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hello Product LLC [Member]", "label": "Hello Product LLC [Member]", "terseLabel": "Hello Product LLC" } } }, "localname": "HelloProductLLCMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "cl_HomeCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Home Care products include laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items.", "label": "Home Care [Member]", "terseLabel": "Home Care" } } }, "localname": "HomeCareMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_InterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate interest and debt related expenses associated with nonoperating financing activities of the entity, less the amount of income derived from investments in debt securities and on cash and cash equivalents, the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.", "label": "Interest expense, net", "terseLabel": "Interest (income) expense, net" } } }, "localname": "InterestExpenseNet", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "cl_InterestIncomeExpenseNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest (Income) Expense, Net [Member]", "label": "Interest (Income) Expense, Net [Member]", "terseLabel": "Interest (income) expense, net" } } }, "localname": "InterestIncomeExpenseNetMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "cl_InventoryNetIncludingNoncurrent": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.colgate.com/role/InventoriesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory, Net, Including Noncurrent", "label": "Inventory, Net, Including Noncurrent", "totalLabel": "Total Inventories, net" } } }, "localname": "InventoryNetIncludingNoncurrent", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "cl_LossContingencyCasesResultingInAdverseJuryVerdictNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "label": "Loss Contingency, Cases Resulting In Adverse Jury Verdict, Number", "terseLabel": "Loss contingency, number of cases resulting in adverse jury verdict" } } }, "localname": "LossContingencyCasesResultingInAdverseJuryVerdictNumber", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_LossContingencyClaimsPreviouslyDismissedNumberAffirmedOnAppeal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Claims Previously Dismissed, Number Affirmed On Appeal", "label": "Loss Contingency, Claims Previously Dismissed, Number Affirmed On Appeal", "terseLabel": "Loss contingency, claims previously dismissed, number affirmed on appeal" } } }, "localname": "LossContingencyClaimsPreviouslyDismissedNumberAffirmedOnAppeal", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_LossContingencyNumberOfCasesOnAppeal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Cases On Appeal", "label": "Loss Contingency, Number Of Cases On Appeal", "terseLabel": "Loss contingency, number of cases on appeal" } } }, "localname": "LossContingencyNumberOfCasesOnAppeal", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "cl_NumberOfDividendsDeclaredPerQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Dividends Declared Per Quarter", "label": "Number Of Dividends Declared Per Quarter", "terseLabel": "Number of dividends declared per quarter" } } }, "localname": "NumberOfDividendsDeclaredPerQuarter", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical" ], "xbrltype": "integerItemType" }, "cl_NumberOfProductSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Product Segments", "label": "Number Of Product Segments", "terseLabel": "Number of product segments (in segments)" } } }, "localname": "NumberOfProductSegments", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "cl_OralCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oral Care products include toothpaste, toothbrushes, mouth rinses and other similar items.", "label": "Oral Care [Member]", "terseLabel": "Oral Care" } } }, "localname": "OralCareMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_OralPersonalAndHomeCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oral, Personal and Home Care", "label": "Oral, Personal and Home Care [Member]", "terseLabel": "Oral, Personal and Home Care" } } }, "localname": "OralPersonalAndHomeCareMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification and Tax", "label": "Other Comprehensive Income (Loss), Hedged Item In Net Investment Hedge, Gain (Loss), Before Reclassification And Tax", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "OtherComprehensiveIncomeLossHedgedItemInNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "cl_PercentageOfConsolidatedNetSalesComingFromEmergingMarkets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Consolidated Net Sales coming from Emerging Markets", "label": "Percentage Of Consolidated Net Sales Coming From Emerging Markets", "terseLabel": "Percentage of consolidated Net sales coming from emerging markets" } } }, "localname": "PercentageOfConsolidatedNetSalesComingFromEmergingMarkets", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Consolidated Net Sales represented by Sales outside US", "label": "Percentage Of Consolidated Net Sales Represented By Sales Outside US", "terseLabel": "Percentage of consolidated Net sales represented by sales outside US" } } }, "localname": "PercentageOfConsolidatedNetSalesRepresentedBySalesOutsideUS", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "cl_PersonalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal Care products include bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants and other similar items.", "label": "Personal Care [Member]", "terseLabel": "Personal Care" } } }, "localname": "PersonalCareMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_PetNutritionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pet Nutrition", "label": "Pet Nutrition [Member]", "terseLabel": "Pet Nutrition" } } }, "localname": "PetNutritionMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cl_RestructuringNetOfCash": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of noncash restructuring costs net of cash payments.", "label": "Restructuring, net of cash", "terseLabel": "Restructuring and termination benefits, net of cash" } } }, "localname": "RestructuringNetOfCash", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "cl_ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "label": "Schedule Of Cash Flow And Net Investment Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of gains (losses) included in Other Comprehensive Income" } } }, "localname": "ScheduleOfCashFlowAndNetInvestmentHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "cl_TaxAssessmentsWithInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of tax assessment with estimated interest accrued as of the balance sheet date arising from income tax examinations related to an acquisition.", "label": "Tax Assessments With Interest", "verboseLabel": "Brazilian internal revenue authority, matter 1" } } }, "localname": "TaxAssessmentsWithInterest", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_TaxAssessmentsWithInterestAndPenalties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of tax assessment with estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations related to investments held by a foreign subsidiary.", "label": "Tax Assessments With Interest And Penalties", "verboseLabel": "Brazilian internal revenue authority, matter 2" } } }, "localname": "TaxAssessmentsWithInterestAndPenalties", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "cl_UnearnedCompensation": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation", "negatedLabel": "Unearned compensation" } } }, "localname": "UnearnedCompensation", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "cl_UnearnedCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for unearned compensation is also recorded.", "label": "Unearned Compensation [Member]", "terseLabel": "Unearned Compensation" } } }, "localname": "UnearnedCompensationMember", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "cl_WithholdingTaxDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Withholding Tax Due", "label": "Withholding Tax Due", "terseLabel": "Withholding tax due" } } }, "localname": "WithholdingTaxDue", "nsuri": "http://www.colgate.com/20210331", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r170", "r183", "r184", "r185", "r186", "r188", "r190", "r194" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r170", "r183", "r184", "r185", "r186", "r188", "r190", "r194" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r357", "r362", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r531", "r534" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r357", "r362", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r531", "r534" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r197", "r266", "r267", "r489", "r530", "r532" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r197", "r266", "r267", "r489", "r530", "r532" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r298", "r357", "r362", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r531", "r534" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r298", "r357", "r362", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r531", "r534" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r198", "r199", "r266", "r268", "r533", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r198", "r199", "r266", "r268", "r533", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r19", "r203", "r204" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Receivables (net of allowances of $89 and $89, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r14", "r498", "r514" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Accrued income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r59", "r64", "r66", "r417" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Retirement plans and other retiree benefits adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r36", "r228" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r64", "r73", "r416" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r60", "r64", "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "terseLabel": "Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r56", "r62", "r63", "r64", "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "negatedLabel": "Accumulated other comprehensive loss, cumulative translation losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r22", "r62", "r63", "r64", "r516", "r539", "r542" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r469", "r470", "r471", "r472", "r473", "r475" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r61", "r64", "r66", "r111", "r112", "r113", "r417", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "verboseLabel": "Total Other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r57", "r64", "r66", "r417", "r470", "r471", "r472", "r473", "r475" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r371" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r111", "r112", "r113", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r364", "r365", "r372", "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r26", "r205", "r213" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r106", "r178", "r185", "r192", "r209", "r411", "r418", "r467", "r497", "r513" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r52", "r106", "r209", "r411", "r418", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r430", "r435" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r353", "r358" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r353", "r358", "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r393" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r401", "r402", "r403" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "verboseLabel": "Purchase price consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r397" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r397" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r396", "r397" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r397" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Fair value of net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r34", "r102" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r96", "r102", "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of the period", "periodStartLabel": "Cash and cash equivalents at beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r96", "r468" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Gain (loss) on derivative instrument" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Gain (loss) on hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r105", "r106", "r134", "r138", "r139", "r142", "r144", "r152", "r153", "r154", "r209", "r467" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r240", "r241", "r242", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r299", "r445" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity contracts", "verboseLabel": "Commodity Contracts" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per common share (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r111", "r112" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r18" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r69", "r71", "r72", "r79", "r508", "r526" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total Comprehensive income attributable to Colgate-Palmolive Company" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r69", "r71", "r78", "r409", "r410", "r422", "r507", "r525" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r69", "r71", "r77", "r408", "r422", "r506", "r524" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive income including noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r76", "r84", "r505", "r523" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r160", "r161", "r201", "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r160", "r161", "r201", "r465", "r466", "r543" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r160", "r161", "r201", "r465", "r466", "r543" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r160", "r161", "r201", "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percent of net sales" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r160", "r161", "r201", "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r183", "r184", "r185", "r186", "r188", "r194", "r196" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r82", "r106", "r209", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Estimated fair value of long-term debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r44", "r108", "r258", "r259", "r260", "r261", "r476", "r477", "r478", "r512" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Debt [Member]", "terseLabel": "Foreign Currency Debt" } } }, "localname": "DebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r374", "r375" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r374", "r375" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r101" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r276", "r314", "r341", "r347", "r348" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Amortization of actuarial loss (gain)" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r291", "r299", "r301", "r345", "r347", "r348" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Voluntary benefit plan contribution" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r276", "r313", "r340", "r347", "r348" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r276", "r280", "r312", "r339", "r347", "r348" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r310", "r337", "r347", "r348" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "verboseLabel": "Components of net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r278", "r311", "r338", "r347", "r348" ], "calculation": { "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r100", "r173" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r53", "r54", "r462" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Total gain (loss) on hedges recognized in income" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r431", "r434", "r440", "r446" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r429", "r431", "r440" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r429", "r431", "r440", "r446", "r447", "r450", "r453" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r53", "r54", "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional values" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r262", "r511" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r352", "r356", "r361" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r80", "r120", "r121", "r122", "r123", "r124", "r131", "r134", "r142", "r143", "r144", "r148", "r149", "r509", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic EPS (in dollars per share)", "verboseLabel": "Earnings per common share, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME", "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Per Share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r80", "r120", "r121", "r122", "r123", "r124", "r134", "r142", "r143", "r144", "r148", "r149", "r509", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted EPS (in dollars per share)", "verboseLabel": "Earnings per common share, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME", "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r145", "r146", "r147", "r150" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "terseLabel": "Cash flow hedges [Abstract]" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r468" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on Cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r111", "r112", "r113", "r117", "r125", "r127", "r151", "r210", "r257", "r262", "r367", "r368", "r369", "r381", "r382", "r469", "r470", "r471", "r472", "r473", "r475", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Derivative and Financial Instruments, Fair Value [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r347", "r455", "r479", "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r454", "r459" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair Value Hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r299", "r301", "r306", "r347", "r455", "r480" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r347", "r479", "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r430", "r436", "r450" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Value Derivatives Balance Sheet Location [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Owned, at Fair Value [Abstract]", "terseLabel": "Other financial instruments" } } }, "localname": "FinancialInstrumentsOwnedAtFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r220", "r222", "r225", "r226", "r490", "r494" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r299", "r444" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts", "verboseLabel": "Foreign Currency Contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r352", "r356", "r361" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "International" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForwardContractsMember": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.", "label": "Forward Contracts [Member]", "terseLabel": "Forward-starting interest rate swaps" } } }, "localname": "ForwardContractsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r216", "r217", "r496" ], "calculation": { "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r81", "r106", "r178", "r184", "r188", "r191", "r194", "r209", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedge": { "auth_ref": [ "r448" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability hedged in fair value hedging relationship.", "label": "Hedged Liability, Fair Value Hedge", "terseLabel": "Carrying amount of hedged item" } } }, "localname": "HedgedLiabilityFairValueHedge", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": { "auth_ref": [ "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.", "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)", "terseLabel": "Cumulative hedging adjustment included in the carrying amount" } } }, "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r74", "r178", "r184", "r188", "r191", "r194", "r495", "r503", "r510", "r528" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r377", "r378", "r380", "r386", "r388", "r390", "r391", "r392" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r107", "r126", "r127", "r176", "r376", "r387", "r389", "r529" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r97", "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r99" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and other accruals" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r99" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Cash effects of changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r99" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other non-current assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r99" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Changes in Shareholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r135", "r136", "r137", "r144" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "verboseLabel": "Stock options and restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r219", "r223" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r299", "r443" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate swap contracts", "verboseLabel": "Interest Rate Swaps" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails", "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r27", "r214" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r49" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.colgate.com/role/InventoriesDetails_1": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Current Inventories, net", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net, Items Net of Reserve Alternative [Abstract]", "terseLabel": "Inventory, Net, Items Net of Reserve Alternative [Abstract]" } } }, "localname": "InventoryNetItemsNetOfReserveAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails_1": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "negatedTerseLabel": "Non-current inventory, net" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r29", "r30", "r214" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r28", "r214" ], "calculation": { "http://www.colgate.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "cl_InventoryNetIncludingNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r454" ], "calculation": { "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "totalLabel": "Total other financial instruments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r41", "r106", "r186", "r209", "r412", "r418", "r419", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r25", "r106", "r209", "r467", "r501", "r519" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r43", "r106", "r209", "r412", "r418", "r419", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r15", "r256", "r499", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Carrying value of long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsCarryingValueandEstimatedFairValueofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r243", "r244", "r245", "r248", "r249", "r250", "r252", "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss Contingency [Abstract]", "terseLabel": "Loss Contingency [Abstract]" } } }, "localname": "LossContingencyAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledAndDismissedNumber": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The number of claims settled and dismissed during the period.", "label": "Loss Contingency, Claims Settled and Dismissed, Number", "terseLabel": "Loss contingency, claims dismissed or settled, number (in cases)" } } }, "localname": "LossContingencyClaimsSettledAndDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r247", "r251", "r254" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Range of reasonably possible losses" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Loss contingency, new claims filed, number (in cases)" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Loss contingency, pending claims, number (in cases)" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r502" ], "calculation": { "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r48", "r106", "r209", "r467", "r500", "r518" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r96", "r98", "r101" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r67", "r70", "r75", "r101", "r106", "r116", "r120", "r121", "r122", "r123", "r126", "r127", "r140", "r178", "r184", "r188", "r191", "r194", "r209", "r467", "r504", "r522" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to Colgate-Palmolive Company" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r67", "r70", "r126", "r127", "r414", "r421" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net income attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r120", "r121", "r122", "r123", "r131", "r132", "r141", "r144", "r178", "r184", "r188", "r191", "r194" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Basic EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r133", "r141", "r144" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Diluted EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofNotionalValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r276" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "terseLabel": "Non-service related postretirement costs" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]", "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r114", "r115", "r118", "r119", "r128", "r129", "r130", "r211", "r212", "r269", "r270", "r271", "r272", "r370", "r383", "r384", "r385", "r491", "r492", "r493", "r538", "r539", "r540", "r541", "r542" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/UseofEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r111", "r112", "r113", "r262", "r406" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries in which entity operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r178", "r184", "r188", "r191", "r194" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Total operating profit", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing operating income (loss).", "label": "Operating Income (Loss) [Member]", "terseLabel": "Included in Operating profit (loss)" } } }, "localname": "OperatingIncomeLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r183", "r184", "r185", "r186", "r188", "r194" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r423" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r8", "r9", "r10", "r42" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r430", "r450" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r408", "r409", "r416" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest", "terseLabel": "Less: Cumulative translation adjustments attributable to noncontrolling interests" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r64", "r469", "r471", "r475" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r64", "r73", "r469", "r471", "r475" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other comprehensive income (loss), before reclassifications, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r76", "r208", "r469", "r474", "r475", "r505", "r523" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "terseLabel": "Other comprehensive income (loss), before tax", "totalLabel": "Other comprehensive income (loss), pretax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r58", "r62" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Gains (losses) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r58", "r62", "r433", "r438", "r451" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) recognized in OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r62", "r65", "r439" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount reclassified from OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r56" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Cumulative translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (loss) on instruments" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r68", "r71", "r73", "r76", "r257", "r469", "r474", "r475", "r505", "r523" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total Other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r60", "r62" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Retirement plans and other retiree benefit adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r430", "r450" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other accruals" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r430", "r450" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsFairValueofDerivativeInstrumentsandOtherFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other (income) expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r274", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r328", "r332", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r352", "r353", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Retiree Benefits" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r85", "r88", "r109" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other investing activities" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r94", "r232" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "terseLabel": "Payments for restructuring" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfOrdinaryDividends": { "auth_ref": [ "r92" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.", "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfOrdinaryDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r86", "r404" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r86" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Payment for acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r207" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities and investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r87" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r298", "r300", "r306", "r324", "r326", "r327", "r328", "r329", "r330", "r347", "r349", "r350", "r351", "r363" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "verboseLabel": "Retirement Plans and Other Retiree Benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r273", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r328", "r332", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r352", "r358", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Benefits" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r90" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherShortTermDebt": { "auth_ref": [ "r90" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from short-term debt classified as other.", "label": "Proceeds from Other Short-term Debt", "terseLabel": "Short-term borrowing (repayment) less than 90 days, net" } } }, "localname": "ProceedsFromOtherShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r91", "r93", "r109" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from sale of marketable securities and investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r89", "r366" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r67", "r70", "r95", "r106", "r116", "r126", "r127", "r178", "r184", "r188", "r191", "r194", "r209", "r408", "r413", "r415", "r421", "r422", "r467", "r510" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income including noncontrolling interests", "totalLabel": "Net income including noncontrolling interests", "verboseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r35", "r227" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r229", "r520" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "Property, plant and equipment:" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r64", "r66", "r469", "r473", "r475" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedTerseLabel": "Reclassification from AOCI, pretax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r64", "r66", "r73", "r469", "r473", "r475" ], "calculation": { "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Reclassification from AOCI, net of tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Implementation Charges" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails", "http://www.colgate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r232", "r236" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "terseLabel": "Restructuring reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r262", "r371", "r517", "r538", "r542" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r111", "r112", "r113", "r117", "r125", "r127", "r210", "r367", "r368", "r369", "r381", "r382", "r535", "r537" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r328", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r352", "r356", "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r328", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r352", "r356", "r361" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r273", "r274", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r328", "r332", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r273", "r274", "r275", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r325", "r328", "r332", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r169", "r170", "r183", "r189", "r190", "r197", "r198", "r201", "r265", "r266", "r489" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total Net sales", "verboseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r160", "r201" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Net Sales" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails", "http://www.colgate.com/role/AcquisitionsScheduleofRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/OtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r331", "r332", "r335", "r336", "r347" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r431", "r440", "r447" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of gains (losses) recognized in Statements of Income" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of derivative instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of hedged item and cumulative adjustment to carrying amount" } } }, "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r11", "r31", "r32", "r33" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories by Major Class" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Components Of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RetirementPlansandOtherRetireeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of notional values" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r234", "r235", "r237" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/RestructuringandRelatedImplementationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r178", "r181", "r187", "r218" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r178", "r181", "r187", "r218" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Net Sales and Operating Profit by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r165", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r201", "r530" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r165", "r167", "r168", "r178", "r182", "r188", "r192", "r193", "r194", "r195", "r197", "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationNarrativeDetails", "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r83" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossonHedgesRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r99" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r38", "r521" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Notes and loans payable" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/UseofEstimates" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r165", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r201", "r218", "r231", "r233", "r238", "r530" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "verboseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/SegmentInformationScheduleofSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r16", "r17", "r18", "r105", "r106", "r134", "r138", "r139", "r142", "r144", "r152", "r153", "r154", "r209", "r257", "r467" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r47", "r111", "r112", "r113", "r117", "r125", "r127", "r151", "r210", "r257", "r262", "r367", "r368", "r369", "r381", "r382", "r469", "r470", "r471", "r472", "r473", "r475", "r535", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.colgate.com/role/OtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r111", "r112", "r113", "r151", "r489" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r257", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Shares issued for restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r47", "r257", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued for stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r18", "r23", "r24", "r106", "r206", "r209", "r467" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Colgate-Palmolive Company shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r106", "r111", "r112", "r113", "r117", "r125", "r209", "r210", "r262", "r367", "r368", "r369", "r381", "r382", "r406", "r407", "r420", "r467", "r469", "r470", "r475", "r536", "r537" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Net Investment Hedge Activity [Abstract]", "verboseLabel": "Net investment hedges [Abstract]" } } }, "localname": "SummaryOfNetInvestmentHedgeActivityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/FairValueMeasurementsandFinancialInstrumentsScheduleofGainLossIncludedinOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r46", "r263" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r46", "r263", "r264" ], "calculation": { "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r257", "r262", "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Treasury stock acquired" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r155", "r156", "r157", "r158", "r162", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/UseofEstimatesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedTerseLabel": "Valuation allowance against deferred tax asset" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r133", "r144" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Shares (millions)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r131", "r144" ], "calculation": { "http://www.colgate.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.colgate.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r363": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r405": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r423": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4EE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r554": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r555": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r556": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r557": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r558": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r559": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" } }, "version": "2.1" } ZIP 63 0000021665-21-000010-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000021665-21-000010-xbrl.zip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end